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A B S T R A C T
Background
Cataract accounts for 50% of blindness globally and remains the leading cause of visual impairment in all regions of the world, despite
improvements in surgical outcomes (WHO 2005). This number is expected to rise due to an aging population and increase in life
expectancy. Although cataracts are not preventable, their surgical treatment is one of the most cost-effective interventions in healthcare.
Objectives
To compare the effects of different surgical interventions for age-related cataract.
Search methods
We searched CENTRAL, MEDLINE, EMBASE up to July 2006, NRR Issue 3 2005, the reference lists of identified trials and we
contacted investigators and experts in the field for details of published and unpublished trials.
Selection criteria
We included randomised controlled trials (RCTS).
Data collection and analysis
Two review authors independently extracted data and discrepancies were resolved by discussion. Where appropriate, risk ratios, odds
ratios and weighted mean differences were summarised after assessing heterogeneity between the studies.
Main results
We identified 17 trials that randomised a total of 9627 people. Phacoemulsification gave a better visual outcome than extracapsular
surgery but similar average cost per procedure in Europe but not in poorer countries. Extracapsular surgery with posterior chamber
lens implant and ICCE with or without an anterior chamber intraocular lens (IOL) implant gave acceptable visual outcomes but
extracapsular surgery had less complications. Manual small incision surgery provides better visual outcome than ECCE but slightly
inferior unaided visual acuity compared to phacoemulsification.
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Authors’ conclusions
This review provides evidence from seven RCTs that phacoemulsification gives a better outcome than ECCE with sutures. We also
found evidence that ECCE with a posterior chamber lens implant provides better visual outcome than ICCE with aphakic glasses. The
long term effect of posterior capsular opacification (PCO) needs to be assessed in larger populations. The data also suggests that ICCE
with an anterior chamber lens implant is an effective alternative to ICCE with aphakic glasses, with similar safety. Phacoemulsification
provides the best visual outcomes but will only be accessible to the poorer countries if the cost of phacoemulsification and foldable IOLs
decrease. Manual small incision cataract surgery provides early visual rehabilitation and comparable visual outcome to PHACO. It has
better visual outcomes than ECCE and can be used in any clinic that is currently carrying out ECCE with IOL. Further research from
developing regions are needed to compare the cost and longer term outcomes of these procedures e.g. PCO and corneal endothelial
cell damage.
P L A I N L A N G U A G E S U M M A R Y
Surgical treatment for cataract caused by aging changes in the lens which reduce its transparency and leads to visual impairment
Cataract is a major cause of global blindness, accounting for 50% to 80% in developing countries. The number of people blind from
cataract is expected to rise due to the increase in life expectancy. Aging causes changes in the lens protein leading to opacification of the
lens. These changes are often bilateral although maybe asymmetric. Symptoms from cataracts include glare, blurred vision, progressive
decrease in visual function and blindness. Surgery is currently the only treatment option once the lens has opacified and vision is
decreasing. The indication for surgery is based on whether the patient’s reduced visual function interferes with their quality of life.
Different surgical techniques have been developed to remove the cloudy lens which is replaced either by an intraocular lens (positioned
in the posterior chamber or the anterior chamber of the eye), aphakic glasses or contact lens. There are four main forms of cataract
extraction surgery: intracapsular (ICCE), extracapsular (ECCE), phacoemulsification (PHACO) and manual small incision (MSICS).
The review authors searched the medical literature and identified 17 randomised controlled trials (9627 participants) investigating the
different surgical interventions. Six of these trials suggested that PHACO gives a better outcome than ECCE. They suggest a better
uncorrected visual acuity (UCVA) following PHACO than ECCE but the majority of the trials showed no difference in best corrected
visual acuity (BCVA) between the two groups. The costs per procedure were not markedly different between the two techniques in
a UK based study, however, a Malaysian study showed ECCE to be significantly cheaper. A study comparing MSICS and ECCE,
advocated MSICS as the procedure of choice due to equal costs and better visual results. Two studies compared the results of PHACO
and MSICS. Phacoemulsification having a significantly higher proportion of patients with UCVA > 6/18 (81.1% versus 71%) but
there was no difference in BSCVA. Trials comparing costs of PHACO and MSICS are important for future research. Manual small
incision surgery offers an alternative technique in developing countries as it provides acceptable visual outcomes when compared to
PHACO yet is likely to be more economical as it avoids the initial outlay of costs of PHACO. It is important to remember that the
studies in this review were based in a variety of countries and situations (hospital based or cataract camps); a knowledge of the setting
is vital before drawing conclusions from the data.
B A C K G R O U N D
Introduction
The World Health Organization estimated from a recent global
review of surveys that there are 37 million people worldwide who
were blind in 2002 (Passolini 2004; Resnikoff 2004) and that age-
related cataract remained the leading cause of blindness globally
in 2002 as it was in 1990. Fifty per cent of total world blindness is
thought to be due to cataract and the majority of blinding cataract
is found in developing countries. This is despite an increasing
number of visually impaired and blind people gaining access to
cataract surgical services due to the development of prevention of
blindness programmes in many countries (Kupfer 1994). In India
alone over three million cataract surgeries are now performed an-
nually (Gupta 1998). Despite these positive trends the number of
people blind due to cataract is increasing because of the changing
demographic structure of populations (Limburg 1996; Minassian
1990; Thylefors 1998). More than 82% of all blind persons are
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50 years of age or older. The contribution of cataracts to blind-
ness globally is likely to grow due to an ageing population and
unsuccessful attempts to control this blinding condition in low
and middle-income countries (WHO 2005).
Blindness and severe visual impairment have a significant impact
on the socioeconomic development of individuals and societies.
Cataract surgical treatment leads to
substantial long-term savings in health-care and social expendi-
tures. Savings also accrue from the reduced commitment made
by family members caring for a visually impaired person. Females
have a significantly higher risk of cataract blindness or being visu-
ally impaired than males mainly because of their higher incidence
of cataract and inadequate access to eye health care, which is of-
ten provided preferentially to males (WHO 2005). The resulting
downward socioeconomic spiral can be reversed through widely
available, appropriate, cost-effective and curative interventions.
It is estimated that the present number of 20million cataract blind
will double by the year 2020. The global initiative “Vision 2020:
The Right to Sight” has suggested various strategies to reduce
cataract blindness (Foster 2001). TheWorld Health Organization
has called for a dramatic increase in surgical volumes worldwide,
but the outcomes of cataract surgery are not always good and this
needs to be investigated further (Venkatesh 2005).
Treatment of cataract
Opacification of the lens occurs as a result of denaturation of lens
proteins and this is not thought to be reversible. Some interven-
tions for preventing or delaying the development of cataract are
used but their effectiveness has not been proven. Surgery is cur-
rently the only treatment option once the lens has opacified and
vision is decreasing.
Intracapsular cataract extraction (ICCE) gained popularity in the
1960s and1970s (Elder 1969) and is still widely used indeveloping
countries. The whole lens with intact capsule is removed from the
eye. The function of the removed lens can be replaced either by
the insertion of an intraocular lens (IOL) usually in the anterior
chamber, or by the use of aphakic glasses or contact lens. Themain
advantage of ICCE is that it is a standardised technique that can
be performed by trained surgeons rapidly (three to five minutes)
with minimal manipulation of the eye. The secondary problem of
opacification of the lens capsule, with the need for further surgical
or laser intervention, is avoided with this technique.
Extracapsular cataract extraction (ECCE) was introduced with the
development of microsurgical techniques in the early 1980s. The
lens contents are removed through a large 12 mm incision leaving
the posterior lens capsule intact. A posterior chamber IOLcan then
be placed in the capsular bag (Apple 1989; Duane 1986). If no
IOL is implanted, aphakic glasses or contact lenses must be used.
Extracapsular surgery has become the preferred method of extrac-
tion in economically advantaged countries and most surgeons in
developing countries have been trained to use this method.
Further technological development has led to a majority of sur-
geons in developed countries adopting sutureless ECCE surgery
(Norregaard 1999). This surgery uses either mechanical fragmen-
tation (phacoemulsification) of the lens nucleus (Mehta 1999),
or a manual fragmentation technique (Blumenthal 1992; Hennig
1999). Both suture and sutureless ECCE leave in place the poste-
rior capsule of the lens. This keeps the anatomical barrier between
the posterior and anterior segments of the eye and may reduce
the risk of posterior segment complications. The disadvantage of
all the extracapsular techniques is that the posterior lens capsule
can become cloudy (Apple 1992) with the need for a primary or
secondary capsulotomy by surgery or using a YAG laser. This in-
creases the costs of surgery and incurs the risk of secondary com-
plications (Javitt 1992).
Phacoemulsification is the most commonly performed method of
cataract extraction in the developed world and involves ultrasonic
fragmentation of the crystalline lens. The incision is small (3.2
mm) which allows rapid visual rehabilitation postoperatively and
low induced astigmatism. This technique requires a phacoemulsi-
ficationmachine whichmay cost £20,000 to £45,000 and has high
disposable and maintenance costs. Phacoemulsification requires
extensive surgical training, particularly the necessity to carry out
a continuous capsulorhexis.
Manual small incision cataract surgery (MSICS)was first described
by Blumenthal (Blumenthal 1994). In Asia and Africa there has
been a renewal of interest in this technique (Ruit 2000) as an
alternative to phacoemulsification because it is considerably less
costly but has similar benefits of rapid visual recovery and reduced
astigmatism (Yorston 2005). It involves a 6 to 6.5 mm scleral
incision, just large enough to allow insertion of a 6 mm IOL.
There are various different techniques described for performing
the capsulotomy in MSICS, for example, the can-opener method
(Gogate 2005), the continuous curvilinear capsulorhexis (PUNE)
and the endocapsular technique where the incision is from pupil
margin to pupil margin. The cataract is delivered into the anterior
chamber hydroextracted and aspirated. The posterior capsule of
the lens is left intact. This technique is technically more difficult
than a standard manual ECCE.
In addition there is a growing realisation that substantial barriers
to surgery still exist, especially in rural areas of developing coun-
tries (Fletcher 1999; Snellingen 1998; Vaidyanathan 1999). This
complexmix of rapid development of technology, increasing num-
bers of people blind due to cataract, and barriers to surgery will
demand the development of quality information systems, which
can monitor outcomes and develop comparative cost models, ac-
cessible to both providers and consumers.
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O B J E C T I V E S
The aim of this review was to examine the effects of themain types
of surgery currently used to treat age-related cataract.
M E T H O D S
Criteria for considering studies for this review
Types of studies
This review included randomised controlled trials only.
Types of participants
Participants in the trials were people with age-related cataract.
Types of interventions
We included the following interventions in this review:
• phacoemulsification with a posterior chamber lens implant;
• manual small incision cataract surgery with a posterior
chamber lens implant;
• extracapsular extraction with or without a posterior
chamber intraocular lens implant;
• intracapsular extraction with or without an anterior
chamber intraocular lens implant.
We also considered the different ways in which the lens may be
removed in extracapsular extraction. We defined these as:
• techniques requiring the placement of sutures;
• techniques not requiring the placement of sutures with the
lens removed after phacoemulsification or manual fragmentation.
Types of outcome measures
Primary outcomes
The primary outcome for this review was:
(1) Late postoperative visual acuity at one year ormore after surgery
in all studies presented as:
(a) the proportion of people with a poor visual outcome after
surgery - defined as best corrected vision of worse than 6/60 in the
operated eye (BCVA < 6/60);
(b) the proportion of people not achieving good functional vision
- good functional vision is defined as vision better than or equal
to 6/18 in the operated eye with usual spectacle correction.
Secondary outcomes
Secondary outcomes for this review include:
(2) Early postoperative visual acuity at 4 to 12 weeks after surgery
presented as:
(a) the proportion of people with a poor visual outcome after
surgery - defined as best corrected vision of worse than 6/60 in the
operated eye (BCVA < 6/60);
(b) the proportion of people not achieving good functional vision
- good functional vision is defined as vision better than or equal
to 6/18 in the operated eye with usual spectacle correction;
(3) complications during surgery, for example, capsular rupture
with or without vitreous loss, iris prolapse and early postoperative
complications such as postoperative inflammation;
(4) complications at one year or more after surgery including the
proportionof participantswith retinal detachment, glaucoma, cys-
toid macular oedema, corneal decompensation, posterior capsule
opacification;
(5) corneal endothelial cell loss;
(6) visual function other than visual acuity (visual perception,
peripheral vision, sensory adaptation, depth perception);
(7) quality of life (self-care, mobility, social and mental function);
(8) costs.
Search methods for identification of studies
Electronic searches
We identified trials from the Cochrane Central Register of Trials -
CENTRAL (which contains theCochrane Eyes and Vision Group
Trials Register) on The Cochrane Library, MEDLINE, EMBASE
and the National Research Register (NRR).
See:Appendices for details of search strategies for each database.
Searching other resources
We searched the reference lists of identified included studies. We
contacted study authors and other experts in the field to identify
unpublished studies or studies sent for publication or in press.
There were no language restrictions in the searches for trials.
Data collection and analysis
Selection of trials
Two review authors independently screened the titles and abstracts
resulting from the electronic searches. Full copies were obtained of
any report referring to definitely or possibly relevant trials. These
full copieswere assessed according to the definitions in the ’Criteria
for considering studies for this review’. Only trials meeting these
criteria were assessed for methodological quality.
Assessment of methodological quality
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Trial quality was assessed according to methods set out in section
6 of the Cochrane Handbook for Systematic Reviews of interventions
(Higgins 2005b). Five parameters were considered: allocation con-
cealment, method of allocation to treatment, documentation of
exclusions, completeness of follow-up, methods of documentation
of complications. Each parameter of trial quality was graded: A -
low risk of bias; B - moderate risk of bias; C - high risk of bias.
Two review authors independently assessed the trial quality and
disagreementwas resolved by discussion. Authors were notmasked
to the report authors and trial results during the assessment.
Data collection
Data were extracted using a form developed by the Cochrane Eyes
and Vision Group. Two authors extracted data and compared the
results for differences. Discrepancies were resolved by discussion.
Data synthesis
Data from studies collecting comparable outcome measures with
similar follow-up times were analysed using either the risk ratio,
odds ratio or weighted mean difference. Where it was appropriate
to pool results we used a fixed-effect model because of the low
number of trials in each comparison. We assessed heterogeneity
between trial results using a chi-square test. If the studies showed
quite different results we did not combine them, even though the
test for heterogeneity was not significant, as we felt that it would
have low power in these situations.
Sensitivity analysis
We planned to conduct sensitivity analyses to assess the effect of
study quality on effect size. There are not enough trials included
at present to conduct any sensitivity analyses.
Updating the review
The original protocol only looked at studies with postoperative
visual acuity results at one year or more. A modification was made
to this protocol to include studies looking at postoperative visual
outcome at six weeks and beyond. The authors updating the re-
view felt that early visual stabilisation is achieved with certain sur-
gical techniques : phacoemulsification and manual small incision
surgery. These studies were carried out in countries where longer
term follow up is difficult (George 2005; Gogate 2005; PUNE)
or when it does occur there is a large loss to follow up (LAHAN)
. It cannot be said that the visual outcome at four to 12 weeks is
a perfect representation of long term outcome as we need to take
account of later onset adverse events.
Early visual stabilisation is not achieved for surgical techniques
involving sutures such as ECCE where the visual outcome at six
weeks is affected by suture induced astigmatism (MEHOX).
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
The original electronic searches found a total of 2824 reports. We
obtained the full copy of nine reports of trials that appeared to
meet our inclusion criteria.We excluded three of these trials (Alpar
1984; De Laage 1988; Quentin 1993) (see the Characteristics
of excluded studies table) and included six (LAHAN; MEHOX;
MIOLS; OCTET; SACMS; Vogel 1993).
Updated searches
We updated the searches in October 2005 and new reports were
screened for inclusion. We obtained the full copy of 20 reports of
trials that appeared to meet our inclusion criteria. We excluded
nine of these (Bomer 1995; Bourne 2003; Ford 2005; Hsu 2005;
Jurgens 1997; Leen 1993; Loo 2004; Noske 1988; Ruellan 1994)
(see the ’Characteristics of excluded studies’ table) and included
11 trials (Chee 1999; Dowler 2000; George 2005; Gogate 2005;
Katsimpris 2004; Landau 1999; Laurell 1998; PUNE; Ravalico
1997; Rizal 2003; Waddell 2004). The searches were again up-
dated in August 2006 and out of 53 new reports of trials; we have
identified three that may meet our inclusion criteria and are wait-
ing further review assessment (Guo 2005; Liang 2006; Parmar
2006).
Results of the search
A summary of the included studies is presented below. Further
details can be found in the ’Characteristics of included studies’
table.
Included studies
Types of participants and settings
Size of study
The 17 included trials can be divided into three groups depending
on size of study:
• seven smaller trials (less than 100 participants): Chee 1999,
Dowler 2000, Katsimpris 2004, Landau 1999, Laurell 1998,
Ravalico 1997, Rizal 2003;
• seven intermediate trials (101 to 999 participants): George
2005, Gogate 2005; MEHOX, OCTET, PUNE, Vogel 1993,
Waddell 2004;
• three larger trials (more than 1000 participants): LAHAN;
MIOLS; SACMS.
Location of study
It should also be noted that these trials were conducted in differ-
ent regions of the world and the participants were recruited from
various settings:
• in Europe: Dowler 2000 (tertiary eye hospital), Katsimpris
2004 (general hospital), Landau 1999 (eye hospital), Laurell
1998 (eye hospital), MEHOX (2 centres: tertiary eye hospital,
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teaching hospital), OCTET ( teaching hospital), Ravalico 1997
(university hospital), Vogel 1993 (university hospital);
• in the Far East: Chee 1999 (teaching hospital), Rizal 2003
(teaching hospital);
• in the Indian Subcontinent: George 2005 (community
based eye hospital), Gogate 2005 (community based eye
hospital), LAHAN (rural eye hospital), MIOLS (rural hospital
and screening eye camps); PUNE (community based eye
hospital), SACMS (3 centres: rural eye hospital, national training
hospital, eye camps);
• in Africa: Waddell 2004 (rural outreach clinics).
Clinical subgroups (for inclusion and exclusion criteria, see the par-
ticipants section in the ’Characteristics of included studies’ table)
Dowler 2000: This study was conducted on diabetic patients only.
Katsimpris 2004: All the patients in this study had pseudoexfoli-
ation, small pupil and small to moderate phacodenesis, which is
known to be a complicated subgroup of cataract patients that was
often excluded from other study populations.
Waddell 2004: This study was carried out in Africans, prolonged
iritis is known to occur in this patient subgroup (Johnson 2000)
Age of Participants
The majority of trials recruited participants aged 40 years and
above, with the exception of OCTET, Ravalico 1997 and Vogel
1993 where participants were aged over 55 years and Landau 1999
and Laurell 1998 where the participants were aged over 68 years.
Types of interventions
Two studies compared intracapsular extraction with aphakic
glasses to intracapsular extraction with an anterior chamber lens
(LAHAN; SACMS). Two studies compared intracapsular extrac-
tion with aphakic glasses or anterior chamber intraocular lens to
extracapsular extraction with a posterior chamber lens (MIOLS;
Waddell 2004). Phacoemulsification has been compared with ex-
tracapsular cataract surgery in nine trials (Chee 1999; Dowler
2000;George 2005;Katsimpris 2004; Landau 1999; Laurell 1998;
MEHOX; Ravalico 1997; Rizal 2003). Two studies compared
phacoemulsification with manual small incision cataract surgery
(George 2005; Gogate 2005). Two studies compared extracapsu-
lar cataract surgery with manual small incision cataract surgery
(George 2005; PUNE). Two studies used lens types that are no
longer in use either because of unacceptable complications or be-
cause the lens has been replaced by an improved model (OCTET;
Vogel 1993). Data for these studies are presented separately.
Follow-up
Follow-up ranged from one month (Ravalico 1997) to five years
(LAHAN).
Outcomes
Distance visual acuitywasmeasured in all trials using either Snellen
acuity or LogMAR scale with the EDTRS chart. Clinical compli-
cations were usually presented. Endothelial cell loss was assessed
in five studies (George 2005; MEHOX; OCTET; Ravalico 1997;
SACMS). Postoperative inflammation was reported in four stud-
ies (Chee 1999; Dowler 2000; Laurell 1998; Ravalico 1997). Cost
analysis was assessed in three studies (MEHOX; PUNE; Rizal
2003).
Risk of bias in included studies
Method and concealment of allocation to treatment
Six trials state that they used computer generated random number
lists as themethodof producing a random sequence (Dowler 2000;
George 2005; Landau 1999; Laurell 1998; Rizal 2003, Waddell
2004). Two trials state that allocation schedules were allocated by
the trial statisticians (Gogate 2005, MEHOX).
The method of concealment used to deliver the sequence of treat-
ment allocation in six studies was sealed opaque envelopes (Gogate
2005; LAHAN;MEHOX;MIOLS; SACMS;Waddell 2004) and
in one study ballots were drawn (PUNE). The delivery system for
concealment of allocation was not stated in Dowler 2000, George
2005, Landau 1999; Laurell 1998 and Rizal 2003.
For the other trials, it is simply stated that the groups were ran-
domly allocated and details of method and delivery of randomi-
sation were not stated (Chee 1999; Katsimpris 2004; OCTET;
Ravalico 1997; Vogel 1993).
Documentation of exclusions
There were no exclusions after treatment allocation in ten trials
(Chee 1999; Dowler 2000; Gogate 2005; LAHAN; Landau 1999;
MIOLS; OCTET; PUNE; Ravalico 1997; Rizal 2003). In two
trials, eight people did not receive surgery after treatment allo-
cation (SACMS; Waddell 2004). In MEHOX five people in the
phacoemulsification group were withdrawn after randomisation
compared to 13 in the extracapsular group. Exclusions were not
clearly documented in the other trials (George 2005; Katsimpris
2004; Laurell 1998; Vogel 1993).
Completeness of follow-up
Follow-up rates were good.More than 85% followupwas achieved
in ten studies at time of conclusion (Dowler 2000 100%; George
2005 85%; Gogate 2005 92.5% (phacoemulsification group):
93.5% (manual small incision cataract surgery group (MSICS));
LAHAN 91% (in both groups); MEHOX 89% (phacoemulsifi-
cation group): 86% (extracapsular group); OCTET 99%; PUNE
94.5% (extracapsular group): 96.1% (MSICS group); Ravalico
1997 100%; Rizal 2003 100%; Waddell 2004 89%). In three
studies there was more than 80% follow up at study conclusion
(Landau 1999; Laurell 1998; SACMS 84% in both groups). In
MIOLS 87% of the group receiving an intraocular lens (IOL) and
82% of the group receiving aphakic spectacles were followed up.
In three trials the number of patients seen at last follow up was
not clear (Chee 1999; Katsimpris 2004; Vogel 1993). In general
trials did not report whether people who were lost to follow-up
differed from those who remained in the trial.
Masking of outcome assessment
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This involved masking of the patients and the assessors to type
of surgery that had been performed in each treatment group. For
masking of outcomes, see the methods section in the ’Character-
istics of included studies’ table.
In trials where an IOLwas compared to aphakic spectacles/contact
lenses (LAHAN; MIOLS; OCTET; SACMS) or posterior cham-
ber IOL compared to anterior chamber IOL (Vogel 1993;Waddell
2004),masking of outcome assessment was not possible because of
the spectacle appearance of participants in either arm or the type of
IOLwas obvious from examination of the eye. As in many surgical
trials despite the assessors being masked to the treatment alloca-
tion code it was usually obvious which intervention the participant
had undergone. In the trials comparing phacoemulsification and
extracapsular extraction, participants were said to be masked to
the study group but the assessors were either unmasked (Dowler
2000; Katsimpris 2004; MEHOX; Ravalico 1997; Rizal 2003) or
other studies state that their assessors was masked (Chee 1999;
George 2005; Laurell 1998; Landau 1999) depending on what as-
sessment was being performed. Despite some studies stating that
the assessor was masked when comparing PHACO and ECCE
it seems difficult for this to have been done as the size, location
and suture number in each procedure is obviously different. The
studies involving MSICS were also said to have masked assessors
(George 2005; Gogate 2005; PUNE) which may have been more
likely with the MSICS and PHACO groups but it would have
been obvious at clinical assessment which were the ECCE group.
In most of these studies masking was carried out as much as was
possible for outcomes such as refraction, visual acuity assessment,
endothelial cell counts, UBM and fluorescein angiograms which
were performed by assessors other than those who were carrying
out the postoperative clinical examination.
Intention-to-treat analysis
Fourteen trials analysed all participants who completed follow-up
in the group to which they were randomised (Chee 1999; Dowler
2000; George 2005; Gogate 2005; Katsimpris 2004; LAHAN;
Landau 1999; Laurell 1998;MEHOX;MIOLS; PUNE; SACMS;
Ravalico 1997; Rizal 2003). In the OCTET study it was not clear
if this was done. The analysis was complicated by the fact that for a
small minority of participants, both eyes were enrolled in the trial.
InWaddell 2004 data was analysed both as per randomisation and
also by IOL implanted.
Handling of data for two eyes
In most of the trials, only one eye per person was enrolled in the
trial, thus avoiding difficulties with the analysis of correlated data
for two eyes (Chee 1999; George 2005; Gogate 2005; Katsimpris
2004; LAHAN; Landau 1999; Laurell 1998; MEHOX; MIOLS;
PUNE; SACMS; Ravalico 1997; Rizal 2003). In OCTET 333
eyes from 331 people were enrolled in the trial. Some people were
therefore in more than one treatment group. Since it affects only
a small number of eyes it is considered unlikely to have a major
effect on the results and this complexity was therefore ignored in
the analysis. Two studies were paired eye studies (Dowler 2000;
Waddell 2004) and were not compared to results from non-paired
eye studies.
Effects of interventions
We used the following abbreviations for this section :
ACIOL- anterior chamber intraocular lens
AG - aphakic glasses
BSCVA - best spectacle corrected visual acuity
BCVA - best corrected visual acuity
CSME - clinical significant macular oedema
CV - coefficient of variation
ECC - endothelial cell count
ECCE - extracapsular cataract extraction
ICCE - intracapsular cataract extraction
IOL - intraocular lens
MSICS - manual small incision cataract surgery
PCIOL- posterior chamber intraocular lens
PCO - posterior capsular opacification
PHACO - phacoemulsification
RCT- randomised controlled trials
SIA - surgical induced astigmatism
UBM - ultrasound Biomicroscopy
UCVA - uncorrected visual acuity
(1) PHACO WITH PCIOL VERSUS ECCE WITH PCIOL
We found nine trials that compared these types of surgery (Chee
1999;Dowler 2000;George 2005;Katsimpris 2004; Laurell 1998;
Landau 1999; MEHOX; Ravalico 1997; Rizal 2003).
(a) visual outcomes
Seven studies reported on the visual outcome following surgery.
However, due to the heterogeneity of the data presentation and
the variability in the postoperative time interval at which visual
outcomes were reported, see Table 1, we were unable to put them
in a meta-analysis. We have referred back to the authors to get fur-
ther details of the data. MEHOX reported visual outcomes (both
BSCVA and UCVA) measured at three weeks, six weeks, three
months, six months and one year after surgery. The phacoemul-
sification group achieved a better visual outcome throughout the
follow-up period due to the fact that the extracapsular group expe-
rienced higher levels of astigmatism. One year after surgery, 204/
224 (91%) of the phacoemulsification group achieved visual acu-
ity of 6/9 or better with spectacle correction, compared to 184/
215 (86%) of the extracapsular group (relative risk (RR) 1.06,
95% confidence interval (CI) 0.99 to 1.14) This is similar to
Dowler 2000 (study population of diabetics only and a paired eye
study) where 96% (44/46) of the phacoemulsification group and
83% (38/46) achieved visual acuity of 6/12 or better with specta-
cle correction at one year. Katsimpris 2004 (study population of
pseudoexfoliative cataracts with small pupils) documented signifi-
cantly better BSCVA at one year in the phacoemulsification group
than extracapsular group. Chee 1999; George 2005, Laurell 1998
and Ravalico 1997 showed no significant difference in BSCVA
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between the two groups at respective follow up times. The BCVA
for the seven studies are summarised in Table 2.
Two studies commented on UCVA. In the MEHOX study one
year after surgery, 87/224 (39%) of the phacoemulsification group
achieved unaided visual acuity of 6/9 or better compared to 42/
215 (20%) of the extracapsular group (RR 1.99, 95% CI 1.45 to
2.73). In Chee 1999 83% of phacoemulsification group achieved
6/12 or better compared to 50% in the extracapsular group at two
months.
(b) complications during surgery
In the two largest studies there were significantly more compli-
cations in the extracapsular group. In the MEHOX study, 7.2%
(17/236) of the extracapsular group had peroperative iris prolapse
compared to zero of the phacoemulsification group. Capsule rup-
ture and/or vitreous loss were equally common in the two groups
with 8/246 cases in the PHACO group compared to 9/236 cases
in ECCE group. In the Katsimpris 2004 study there was a sig-
nificantly higher rate of zonular dialysis, capsular tear, and vitre-
ous loss in the extracapsular group. Complications are not com-
mented on in two studies Dowler 2000 and Ravalico 1997 and
in four studies (Chee 1999; George 2005; Landau 1999; Laurell
1998) it is clearly stated that there were no intraoperative compli-
cations. Complications during surgery are statistically compared
in Analysis 1.2.
(c) clinical complications
In MEHOX corneal decompensation was not reported but there
were two retinal detachments, both in the PHACO group, and
five cases of macular oedema (two in the PHACO group and
three in the ECCE group). In Katsimpris 2004 there was less mac-
ula oedema (2.1% v 16.8%) in the PHACO group compared to
ECCE group. It was not possible to ascertain from the papers
whether the same patients who had PC tear +/- vitreous loss were
the same as those who developedmacula oedema.We have statisti-
cally compared themacula oedema rates inAnalysis 1.1. There was
nodifference in IOLdecentrationbetween the twogroups. Landau
1999 found a significantly higher rate of intraocular lens haptic
subluxation in the extracapsular group. Three studies commented
on the development of posterior capsule opacification (PCO), one
was a paired eye study (Dowler 2000), and other two were single
eye studies (Katsimpris 2004;MEHOX).MEHOX showed poste-
rior capsule opacification occurred less commonly in the PHACO
group (RR 0.67, 95% CI 0.48 to 0.92). Katsimpris 2004 showed
there was significant less posterior capsule opacification (10.6%
v 38.3%) in patients who underwent PHACO who had pseu-
doexfoliation syndrome and Dowler 2000 found a higher rate of
posterior capsule opacification in the extracapsular group (35% v
11%) indiabetic patients. The population subgroups of these three
studies are not comparable so an overall analysis of PCO was not
carried out. Dowler 2000 found no significant difference between
the two groups with respect to postoperative incidence of pseu-
dophakic macula oedema (four cases PHACO versus six ECCE
cases), postoperative incidence of progression of diabetic retinopa-
thy or development of high-risk proliferative diabetic retinopa-
thy. Three studies showed significantly more inflammation in the
ECCE group in the early postoperative period but no difference at
three months (Chee 1999; Dowler 2000; Laurell 1998). Although
the time interval at which postoperative inflammation is recorded
are similar in the three studies the data is recorded in different
formats, qualitative (Dowler 2000), expressed as median and in-
terquartile range (Laurell 1998) and mean and standard deviation
(Chee 1999), hence we have been unable to compare them statis-
tically. We have contacted the authors of these studies to request
the raw data to undertake the appropriate analysis. Corneal de-
compensation was not reported.
(d) corneal endothelial cell dysfunction
Corneal endothelial cell loss was reported in three studies. How-
ever, due to the heterogeneity in follow up time (Ravalico 1997
- 30 days, George 2005 - 6 weeks, MEHOX - 1 year) it was not
possible to compare them statistically. We have contacted the au-
thors of the latter study to request the raw data at six weeks to
undertake the appropriate meta-analysis.
Ravalico 1997 showed a significant increase in endothelial perme-
ability, corneal thickness and coefficient of variation in the early
postoperative period in the extracapsular group.Three studies have
shown no difference in mean percentage endothelial cell loss be-
tween the two groups at respective follow up times (George 2005
(4.72% ECCE v 5.41% PHACO), Ravalico 1997 (10.1% ECCE
v 8.5% PHACO), MEHOX (9.1% ECCE v 10.5% PHACO).
In the MEHOX study however PHACO was associated with a
higher risk of severe cell loss in patients with hard cataract (P =
0.04 RR 3.7, 95% CI 1.03 to 13.34).
(e) costs
Two studies have looked at cost in different economic settings.
In the MEHOX study in the UK, the average cost of PHACO
was similar to ECCE i.e. £332.89 compared to £335.07. Rizal
2003 in Malaysia found ECCE to be significantly cheaper than
PHACO i.e. RM 1,664.46 (RM 1,233.04 to RM2,377.64) v RM
1,978.00 (RM 1,557.87 to RM 3,334.50). However, the follow
up was short (only 2 months) and the study did not include future
clinic visits for removal of sutures.
(2) PHACO WITH PCIOL VERSUS MSICS WITH PCIOL
Two studies have compared this intervention (George 2005;
Gogate 2005).
(a) visual outcomes
In Gogate 2005 1.6% (3/185) of the PHACO group and 1.6%
(3/187) of the MSICS group had BCVA worse than 6/18 i.e. did
not achieve functional vision at 6 weeks RR 1.01 (95%CI 0.21 to
4.94). 0.5% of the PHACO group and 0% of the MSICS group
have a poor outcome following surgery (BSCVA < 6/60). In the
George 2005 study there was only 1 patient with BSCVA worse
than 6/18 (who was in the MSICS group). We have statistically
compared the visual outcomes in Analysis 2.1 and Analysis 2.2.
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(b) complications during surgery
Gogate 2005 showed 7/199 (3.5%) of the PHACO group and 12/
201 (6%) of theMSICS had PC tears (P = 0.43). Both groups had
2patientswith iridodialysis and1with zonule dialysis.One patient
in the PHACO group had a drop nucleus and one in the MSICS
group had a detachment ofDescemet’smembrane. Twopatients in
the PHACOgrouphad an extensionof their anterior capsulorhexis
and another 2 had to convert to MSICS due to intraoperative
difficulty. There were no intraoperative complications from the
George 2005 study. The PC tear/ vitreous loss are statistically
compared in Analysis 2.3.
(c) clinical complications
From Gogate 2005 4 (PHACO) v 5 (MSICS) patients developed
iritis postoperatively. Nine per cent (18/185) PHACO and 4.5%
(9/187) MSICS (P = 0.073) developed corneal oedema on the first
day which had resolved by 6 weeks in both groups. Three patients
developed a shallow anterior chamber on day 1 (1 PHACO, 2
MSICS). Three patients in the PHACO and 4 in the MSICS
had retained cortical matter. There was no documentation about
postoperative complications in George 2005.
(d) corneal endothelial cell count
George 2005 showed no statistically significant difference in en-
dothelial cell loss between the two groups. The sample size of the
study was adequate to detect a difference of 7% in endothelial cell
loss between techniques with a power of 80%. There was a mean
5.41% (N = 60,SD 10.99) induced cell loss in PHACO at 6 weeks
follow-up compared with 4.21% (N = 53, SD 10.29) for MSICS.
(3) ECCE WITH PCIOL VERSUS MSICS WITH PCIOL
Two studies have compared this intervention (George 2005;
PUNE).
(a) visual outcomes
In the PUNE study 13.3% (48/362) of the ECCE group and 10.2
% (35/344) of the MSICS group had a BSCVA < 6/18 i.e. a poor
functional visual outcome in the operated eye RR 1.30 (95%CI
0.86 to 1.96), there was no significant difference between the two
groups (see Analysis 3.2). Four patients (1.1%) in ECCE group
and 6 (1.7%) in MSICS group had poor visual outcome (BSCVA
<6/60) in the operated eye, there was no significant difference
between the two groups. In George 2005 1/53 cases had BSCVA
< 6/18 in MSICS group compared to 5 in the ECCE group (3
related to high astigmatism, 1 posterior capsule opacification and
1 anterior ischaemic optic neuropathy). Only one patient, had a
VA < 6/60 and they were in the ECCE group (see Analysis 3.1).
(b) complications during surgery
In the PUNE study, 21 of the patients in the MSICS group were
converted to ECCE either due to density of cataract or because of
small pupil. Seventeen of the ECCE group and 29 of the MSICS
group had intraoperative complications RR 1.04 (95% CI 1 to
1.08) this was not significantly different. Ten out of 383 (6 with
vitreous loss) in the ECCE group and 18/358 (6 with vitreous
loss) in the MSICS had posterior capsule tears OR 0.51 (95% CI
0.23 to 1.11) (see Analysis 3.3). Two patients in theMSICS group
had iridodialysis. There were no complications during surgery in
the George 2005 study (we have reaffirmed this by contacting the
author).
(c) clinical complications
In the PUNE study 94/383 in the ECCE group and 121/358 in
the MSICS group had postoperative complications in the first 6
weeks RR 1.14 (95% CI 1.04 to 1.25); the majority were mild
(27.1%) (OCTET grade 1). There were no severe complications
(OCTET grade 3), moderate complications were seen in 3/383
ECCE group and 5/358 in the MSICS group RR 1.01 (95% CI
0.99 to 1.02), there was no significant difference between the two
groups. Mild complications e.g. descemet’s folds, iritis and corneal
oedema were more commonly seen in MSICS group (32.4% v
23.7% ECCE group). Posterior capsule opacification was seen
equally in both groups (3/383 ECCE v 4/358 MSICS).
(d) corneal endothelial cell count
The George 2005 study showed there was no statistically signif-
icant difference in endothelial cell loss between the two groups.
The sample size was adequate to detect a 7% difference in en-
dothelial cell count between the groups, giving a power of 80%.
There was a mean 4.72% (N = 52, SD 13.07) induced cell loss in
ECCE at 6 weeks follow-up compared with 4.21% (N = 53, SD
10.29) for MSICS.
(e) costs
In the PUNE study there was no significant difference in surgical
time or cost between the two procedures, even accounting for
surgeon variation. The average cost of ECCE was US $15.82,
MSICS US $15.68 of which US $11.34 was a fixed facility cost
common to both. It is not clear from the paper the power of this
study to detect a difference in costing with this sample size hence
we have contacted the authors to clarify this.
(4) ECCE WITH PCIOL VERSUS ICCE WITH ACIOL
One study compared this intervention (Waddell 2004).
(a) visual outcomes
The proportion not achieving good functional vision following
surgery was 18% in the ACIOL group and 16% in the PCIOL
group RR 1.13 (95%CI 0.61 to 2.08). The difference was not sta-
tistically significant. Eleven per cent of patients with ACIOL and
9% of patients with PCIOL had a poor visual outcome following
surgery RR 1.22 (95% CI 0.53 to 2.82). There was no signifi-
cant difference in the final refractions between the two groups. In
this study no biometry was performed, patients received standard
power lens.
(b) complications during surgery
There was no difference in overall incidence of complications be-
tween the two groups.Nine eyes randomised to PCIOLswere con-
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verted to ACIOL because of capsule rupture or zonule dehiscence
at surgery, 1 eye randomised to ACIOL inadvertently received a
PCIOL.
(c) clinical complications
Twelve eyes that received ACIOL underwent secondary proce-
dures; 8 had removal of post-inflammatory membranes, 3 had re-
peat peripheral iridectomy due to iris bombé, 1 had replacement
of displaced lens. Five eyes that received PCIOLs had secondary
procedures. Three had removal of thickened anterior capsule flap,
2 had removal of residual lens matter. Non-surgical interventional
complications occurred in 5 eyes with ACIOL and 3 eyes with
PCIOL. In the ACIOL group, 3 had iris bombé, 1 developed an
anterior chamber blood clot and one developed a hypopyon. In
the PCIOL group 2 eyes developed posterior capsule thickening,
1 eye developed a postoperative anterior chamber blood clot. This
study only addresses IOL implants in African patients hence the
degree of inflammation cannot be extrapolated to patients from
other ethnic groups.
(5) ECCE WITH PCIOL VERSUS ICCE WITH AG
One trial compared these types of surgery (MIOLS).
(a) visual outcomes
Best-corrected vision less than 6/60 occurred in 0.6% of the
ECCE-PCIOL group compared to 1.6% of the ICCE-AG group.
People in the ECCE-PCIOL were less likely to experience a poor
outcome one year after surgery (RR 0.39, 95% CI 0.18 to 0.84).
Functional vision less than 6/18 was recorded in 16% of people
receiving IOLs and 15% of people receiving spectacles (RR 1.08,
95%CI 0.91 to 1.28). This analysis includes 155 participants who
did not present with personal eye glasses at follow-up.
(b) complications during surgery
Vitreous loss during surgery was reported in 1.7% of participants
in the MIOLS. Capsular rupture combined with vitreous loss was
observed in 1.7% of the ECCE-PCIOL group.
(c) clinical complications
Posterior capsular opacification occurred in 9% of the ECCE-
PCIOL group at one year. There were eight cases of corneal de-
compensation, four in each group and eight cases of retinal de-
tachment, three in the ECCE-PCIOL group compared to five in
the ICCE-AG group.Macular oedema, the diagnosis of which was
verified with fluorescein angiography, occurredmore frequently in
the ICCE-AG group. There were 23/1474 in the ECCE-PCIOL
group compared to 59/1401 in the ICCE-AG group (RR 0.37,
95% CI 0.23 to 0.60).
(d) quality of life
The MIOLS study was the only study that examined quality of
life. In both study groups participants’ responses showed large im-
provements in visual functioning and quality of life. With im-
provement in visual acuity from 20/60 to 20/20 there was an in-
crease in visual functioning and quality of life for both procedures
with the advantage of ECCE with PCIOL over ICCE with AG
across all visual categories. The visual functioning and quality of
life sub-scale scores associated with lens implant visual acuity of
20/50 to 20/60 showed consistently the same or slightly better
than participants operated without lens implant associated with
visual acuity scores of 20/20.
(6) ICCE WITH ACIOL VERSUS ICCE WITH AG
Two trials compared these interventions (LAHAN; SACMS).
(a) visual outcomes
Best corrected vision worse than 6/60 was reported in 2.6% of
the ICCE-ACIOL group compared to 2.2% of the ICCE-AG
group in the LAHAN study (RR 1.19, 95% CI 0.66 to 2.14).
In SACMS with data up to two years after surgery, 3.9% of the
ICCE-ACIOL group compared to 3.6% of the ICCE-AG group
had best corrected acuity less than 6/60 one year after surgery (RR
1.06, 95% CI 0.57 to 1.96). The pooled relative risk from these
two studies is 1.13, 95% CI 0.74 to 1.72. The visual outcome
BCVA worse than 6/60 at one year is statistically compared in
Analysis 4.1.
The whole cohort taking part in the LAHAN trial was invited
for re-examination two to five years after surgery; 65% were re-
examined. There were 13 new cases of best corrected acuity less
than 6/60 occurring after one year follow-up, nine in the ICCE-
ACIOL group and four in the ICCE-AG (odds ratio 2.1, 95% CI
0.59 to 9.55). There was no indication that lens-related problems
increased over time.
Functional vision less than 6/18was reported in 55%of the ICCE-
ACIOL group compared to 41% of the ICCE-AG group (RR
1.35, 95% CI 1.22 to 1.49) in the LAHAN study. The visual
outcome BCVA worse than 6/18 at one year for the two studies is
statistically compared in Analysis 4.2.
There were similar numbers of people severely visually impaired
and blind in both groups at all follow-up times. The exception
to this is at one year when there were more people functionally
blind in the ICCE-AG. This occurred due to the loss of aphakic
glasses. There was a 60% reduced risk of functional blindness in
the ICCE-ACIOL group one year after surgery. Significant astig-
matismwas approximately four timesmore common in the ICCE-
ACIOL group compared to ICCE-AG group. Most participants
in both groups had ’against the rule’ astigmatism, 446 or 88.8%
(95% CI 86.0 to 91.6) and 348 or 83.5% (95% CI 79.9 to 87.1)
respectively.
In SACMS pre-operative assessment was not standardised as two
centres used different types of biometry and one centre did not
use biometry. In addition, the results were not presented strictly
according to the definition of functional vision used in this review.
Visual acuity was presented with the entire aphakic group having
+10 spectacle correction. This analysis showed that 51% of the
ACIOL group had functional vision less than 6/18 compared to
46% of the aphakic group (RR 1.10, 95% CI 0.97 to 1.24). As
the outcome is not strictly the same in these two cases, we have
not calculated an overall summary score. In the SACMS a limbal
incision was used in 91% of patients. No comparative data are
available on degree of astigmatism.
(b) complications during surgery
10Surgical interventions for age-related cataract (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
There were similar numbers of peroperative complications in the
two groups in SACMS. Vitreous disturbance leading to vitrec-
tomy occurred in 69/616 (11.2%) of the ICCE-ACIOL group
compared to 58/613 (9.5%) of the ICCE-AG group. In LAHAN
2.9% of the ICCE-ACIOL group received an anterior vitrectomy
compared to 0.4% of the ICCE-AG group.
(c) clinical complications
Corneal endothelial cell loss after six week follow-up was 17% in
the IOL group and 14.4% in the aphakic group (P < 0.05) in the
SACMS trial. After six weeks there was no significant difference
in the continuing cell loss between eyes having no lens compared
to eyes with lens (12 months: IOL 5.3%, AG 4.1%, P = 0.06; 24
months: IOL 3.1%, AG 2.9% P = 0.71).
The LAHAN and SACMS studies reported other complications
related only to severe visual impairment. On the whole, these
complications occurred infrequently. The power of these studies
to detect differences, even when the results are pooled, is therefore
low.
Retinal detachment: There were few cases of retinal detachment
and so the power of these studies to detect a difference was low. At
one year after surgery, there were 8/1430 in the ICCE-AG groups
and 2/1437 in the ICCE-ACIOL groups (pooled RR 0.29, 95%
CI 0.07 to 1.20). However, later follow-up in the LAHAN study
found four more cases of retinal detachment in the ICCE-ACIOL
group, further evidence for little difference between the two groups
in incidence of retinal detachment.
Glaucoma: InLAHAN secondary glaucoma as a cause of visual loss
was reported more commonly in the ICCE-ACIOL group (five
cases) compared to the ICCE-AG group (no cases). Uveitis was
also found more commonly in the ACIOL group compared with
the aphakic group. SACMS reports the presence of secondary glau-
coma at 0.1% with no significant difference between the groups.
Cystoid macula oedema: There were two cases of cystoid macular
oedema in the ICCE-ACIOLgroup in LAHAN compared to none
in the ICCE-AG group. In SACMS three cases in the ICCE-
ACIOL group compared to two in the ICCE-ACIOL group. The
pooled relative risk of having severe visual impairment due to
cystoid macula oedema in the ICCE-ACIOL group compared to
ICCE-AG group was 2.2 (0.49 to 9.79).
Corneal endothelial decompensation: This occurred rarely. In
LAHAN there was one case at one year that occurred in the ICCE-
AG group. No further cases were identified after one year. In
SACMS there was one case in the IOL group.
The clinical complications for retinal detachment, macular
oedema and corneal decompensation are statistically compared in
Analysis 4.3.
(7) STUDIES OF OLDER LENS TYPES
There were two studies that considered older lens types (OCTET;
Vogel 1993). The data for these studies are not presented in the
meta-analyses.
(a) visual outcomes
Best-corrected vision of less than 6/60 was not reported as an out-
come in the OCTET study. In this study, 96% of ICCE without
IOL, 84% of ICCE with iris clip lens and 84% of ECCE with
iridocapsular lens had best corrected vision better or equal to 6/12
at one year after surgery. In Vogel 1993 the vision outcomes at two
years after surgery were presented asmedians andmean. There was
a non-significant difference between the two study groups. In the
ICCE-ACIOL group the mean visual acuity was 0.72 (standard
deviation 0.237) compared to 0.74 (standard deviation 0.194) in
the ECCE-PCIOL group.
(b) complications during surgery
Vitreous loss was reported in 4% of cases in OCTET. Capsular
rupture was reported in 2.5% of OCTET cases. The study found
a total cell loss of 14.9% 24 months after surgery. There was a
significantly higher continuing cell loss with the iridocapsular lens
compared to the iris clip lens or no lens implantation. Many of
these corneas decompensated two years after surgery.
(c) clinical complications
Vogel 1993 reports the presence of secondary glaucoma of 1.2%.
Cystoid macula oedema is reported in both studies. Only Vogel
1993 verified the findings with fluorescein angiography. Posterior
capsular opacification was reported in the three studies that in-
cluded an ECCE group and was the most frequent complication
relating to visual impairment (all grades of impairment) ranging
from 0.5% at one year and 13.5% at four years (in a random sub-
sample) in the MIOLS study to 29.6% in the Vogel 1993 study.
Vogel 1993 also reported a 3.1% frequency of toxic lens syndrome.
D I S C U S S I O N
The studies reported in this review cover a wide range of countries
and this must be considered in the formulation of any recommen-
dations from the data. There is certainly a trend for intracapsular
surgery to be supplanted by ECCE and PCIOL and more recently
in the Indian subcontinent to be supplanted by MSICS. Even
within the Indian subcontinent there is a marked difference be-
tween results of cataract camps and hospital based (Johnson 2000)
treatments so when comparing results from different trials knowl-
edge of the setting of the study is vital.
High volume surgery, which simply means surgical techniques
with high patient throughput, is needed in the Indian subconti-
nent and Africa where cataract is common and resources are lim-
ited with almost three to six million blind from cataract (Dandona
1998; Foster 1991). However, any high volume procedure must
also focus on quality. In a strive for the latter there is a trend
for intracapsular cataract extraction (ICCE) to be replaced with
ECCEwith PCIOL implantation; the former technique is still be-
ing used in up to 40% of total surgeries in some developing coun-
tries (Gupta 1998). The three studies conducted inAsia (LAHAN;
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MIOLS; SACMS) are therefore relevant to the issue of the pre-
vention of cataract blindness.
Comparison of results of the three large studies in South Asia
There were important differences between these trials that need
to be highlighted before interpreting the results. MIOLS was per-
formed by a few surgeons in one centre of excellence using oper-
ating microscopes. The power of the lens required was calculated
using biometry before surgery. The LAHAN study was conducted
in a remote rural eye hospital in the Terai region of Nepal. No
attempt was made to estimate the power of lens required before
surgery. All surgery was done using 4.5 X loupe magnification by
two highly trained surgeons. The SACMS study was similar to
LAHAN and was conducted in three centres, in India (Hyder-
abad), Bangladesh (Chittagong) and western Nepal and 19 sur-
geons undertook the operations. This study may well be more rep-
resentative of usual surgical practice and ability, thereby having a
greater external validity. The data in this review suggest that in-
tracapsular extraction with a modern multiflex anterior chamber
lens implant has similar safety and effectiveness as intracapsular
extraction with aphakic glasses (AG) in the developing country
setting. In the LAHAN and SACMS studies, the risk of a poor
visual outcome (visual acuity less than 6/60) one to two years after
surgery did not increase after implantation of an anterior cham-
ber intraocular lens (ACIOL) compared to intracapsular extrac-
tion without implantation of an intraocular lens (IOL). At one
year follow-up there were more people functionally blind in the
intracapsular extraction with aphakic glasses (control) group due
to the loss of aphakic spectacles. There were three cases of corneal
decompensation identified 12 to 24 months after surgery in 2867
participants. Two of these cases occurred in the control group that
is only one case of corneal decompensation occurred in a person
with an ACIOL. Long term follow-up of up to five years after
surgery did not show any increased risk of corneal decompensa-
tion. In the LAHAN study only, uveitis and secondary glaucoma
occurred more frequently in eyes with an anterior chamber lens
implant. Relatively high rates of uveitis were also seen in a non-ran-
domised trial conducted in a black African population in southern
Africa (Cook 1998). Higher rates of poor visual outcome were
observed in SACMS where many surgeons in three different cen-
tres conducted the operations, however, these were still less than
five per cent (visual acuity 6/60) and there was no increased risk
associated with implantation of anterior chamber lenses. In addi-
tion, corneal endothelial lens measurements in the SACMS study
did not give cause for concern in contrast with previous studies
with now outdated anterior chamber lenses (OCTET). Corneal
decompensation was commonly seen with the first generations of
anterior chamber lenses the first two to five years after implanta-
tion. Clinico-pathological data from developed country settings
have shown no indication that the new generation of ACIOLs
(Apple 2000) have given rise to a new epidemic of corneal com-
plications.
Comparison between intracapsular and extracapsular extrac-
tion.
MIOLS, Vogel 1993 andWaddell 2004 were the only studies that
compared two different surgical techniques. These studies showed
that there were no clinically relevant differences in the visual acuity
distributions of both BSCVA and UCVA between ECCE-PCIOL
and ICCE-AG/ ACIOL. However, 155 patients lost their aphakic
glasses at follow up; an obvious disadvantage. Overall there was
no significant difference in complication incidence between the
two techniques but the studies were not appropriately powered to
detect differences, if the incidence of the complications is small.
However, intracapsular extraction gave a significantly higher fre-
quency of cystoid macular oedema (MIOLS) but this did not sig-
nificantly increase the number of participants with severe vision
loss (< 6/60). The documented secondary procedures by Waddell
2004may be reduced by improved surgical technique in the ECCE
group which would affect the overall results. All of the studies
showed a significant increase of posterior capsular opacification
(PCO) in the ECCE and PCIOL groups, 0.5% at one year and
13.5% after four years (random sub-sample). The long-term ef-
fect on vision will depend on the availability of Nd YAG laser
posterior capsulotomy. Long-term complications of ACIOL, for
example stability in anterior chamber, glaucoma, corneal endothe-
lial cell loss and the effect of training surgeons to perform the
more complicated ECCE-PCIOL procedure were not addressed
in these studies (Waddell 2004). Waddell 2004 was a paired eye
study and was analysed by Wilcoxon matched pairs signed ranks
test. Substantial improvements in vision-related quality of life were
reported by people taking part in the MIOLS study. These im-
provements were more marked in people receiving an IOL com-
pared to people receiving aphakic glasses.
Comparison between phacoemulsification and extracapsular
surgery
The introduction of any new surgical technique requires valida-
tion against the previous gold standard to show an improvement
in quality. There are nine trials that have compared these two
techniques. They suggest a better UCVA following PHACO than
ECCE . The majority of the trials showed no difference in best
spectacle corrected visual acuity (BSCVA) between the two groups
apart from Katsimpris 2004 which showed better vision in the
PHACO group. However, this result may be due to the higher in-
traoperative complications and greater PCO in the ECCE group
affecting vision. The complication rate both early and late was sig-
nificantly lower in the PHACO group in all studies. Even though
the endothelial cell loss was comparable between the two tech-
niques there was a higher risk of severe loss in the PHACO group
associated with removal of dense cataracts. The costs per proce-
dure were not markedly different between the two techniques in
a UK based study (MEHOX), however, a Malaysian study (Rizal
2003) showed ECCE to be significantly cheaper. The results of
this study are limited by the fact the follow up was short and the
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ECCE group of participants still required a minimum of two fur-
ther hospital visits for suture removal which was not accounted
for in the costing. Extrapolation of these costs to other parts of
the world where cataract surgery costs are very different must be
made with caution.
Comparison between phacoemulsification and manual small
incision cataract surgery
In an effort to combat the initial outlay of costs of PHACO,
MSICS is an appealing alternative that may be performed in a
high volume setting. Manual small incision cataract surgery offers
an alterative to developing countries where there is a mixed pop-
ulation of hospital based and camp based cataract services. Two
studies compared results of these two techniques, with PHACO
having a significantly improved proportion of patients with un-
corrected visual acuity (UCVA) >= to 6/18 (81.1% v 71%), there
was no difference in BSCVA. There was no difference in the av-
erage postoperative astigmatism or surgical induced astigmatism
between PHACO andMSICS but significantly less patients had <
1 D astigmatism in the PHACO group (P = 0.04). There was no
statistical difference in the number of patients who did not achieve
functional vision in the operated eye, who had a poor visual out-
come and surgical complications (including endothelial cell loss)
between the two groups. There are few papers comparing costs of
these two techniques as yet.
Comparison between extracapsular extraction and manual
small incision cataract surgery
Studies comparing these two techniques have shown a significantly
better UCVA >= 6/18 and surgical induced astigmatism in the
MSICS group (47.9%) v ECCE group (37.3%) RR 1.21 (95%CI
1.06 to 1.37) (P = 0.0001), but no difference in BSCVA between
the two groups.
There was no significant difference in complications or costs be-
tween the two groups. However, MSICS was advocated as proce-
dure of choice due to equal costs and better unaided visual acuity
results.
An observation from our meta-analyses is the heterogeneity of vi-
sual outcome data and follow up times amongst studies exam-
ining results following PHACO. This made statistical compari-
son between studies difficult and hence a uniform criteria for re-
porting the visual results from PHACO trials needs to be estab-
lished. Firstly it is important that both UCVA and BCVA should
be recorded. A decreased UCVA compared to best corrected vi-
sual acuity (BCVA) maybe due to surgically induced astigmatism,
which has been found to be the case with MSICS (Venkatesh
2005). The difference between UCVA and BCVA often shows
that residual refractive error is a major cause of poor visual out-
come, just considering BCVA underestimates visual impairment.
Therefore it would be useful to report UCVA and BCVA > 6/12,
especially in trials involving PHACO and MSICS in developing
countries. This would give an estimate of the uncorrected refrac-
tive error (Dandona 2006) in patients following cataract surgery
hence a further estimate of the overall cost to the patient. A sug-
gestion would be for each study to report those patients with poor
visual outcomes as those who did not achieve UCVA and BCVA
of 6/60 and who did not achieve UCVA and BCVA of 6/18. They
should also report good visual outcomes, as the number of patients
with postoperative best corrected visual acuity of 6/12 or better
(Desai 1999). This level of vision is often used as the level of vi-
sion required for daily tasks (Congdon 2004). The World Health
Organisation definitions of visual impairment are based only on
distance visual acuity. There may be subsets of persons who have
poor distance vision and good near vision or vice versa and these
may impact on quality of life in different ways (Dandona 2006).
Therefore, it would be useful to record near vision pre and post-
operatively. The difference in the level of astigmatism when com-
paring the surgical techniques is particularly relevant in popula-
tions that have limited access to spectacles. It is clear that sutureless
surgery produces less astigmatism and provides patients with faster
visual recovery and fewer follow-up visits than surgery involving
sutures.
It would also be easier to compare postoperative visual outcomes
at standard time intervals. Although it is reasonable to compare
PHACO and MSICS visual outcomes at six weeks it is not ap-
propriate to compare these with techniques requiring sutures such
as ECCE and ICCE which require a longer period for vision sta-
bilisation due to suture induced astigmatism. A suggested stan-
dard time interval to record visual acuity would be six weeks, three
months and one year postoperatively. It is recognised that long-
term follow up is a challenge especially in developing countries.
Extracapsular cataract surgery is rapidly becoming more popular
in developing countries and replacing ICCE. In India more than
50% of cataract surgeries are ECCE (Gupta 1998), yet there is lit-
tle clinical data which compares intraoperative and long-term out-
comes of extracapsular surgery conducted with sutures and suture-
less surgery techniques (manual phacofragmentation or PHACO).
Particular attention is required to assess the incidence of intraoper-
ative complications (capsular rupture/ vitreous loss) and the long-
term vision threatening complications including the frequency of
PCO. Outcome studies have indicated that prospective follow up
for at least three years would provide such information (Shrestha
2001).
Trials on comparative costing of surgical systems and procedures
are needed to compare the cost benefit in interventionprogrammes
for cataract blindness. Although there have been cost comparisons
of PHACO and ECCE there has been few trials comparing the
cost of MSICS. MEHOX (UK study) found PHACO and ECCE
to have similar costs whereas the Malaysian study (Rizal 2003)
found ECCE to be significantly cheaper, but this study did not in-
clude postoperative clinic visits.Other reports in the literature have
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documented higher providers costs for PHACO in comparison to
ECCE (Asimakis 1996). Muralikrishnan 2004 looked at the eco-
nomic cost of cataract surgery for PHACO, ECCE with IOL and
MSICS in Southern India. The providers costs were highest for
PHACO (US $25.55) compared to MSICS ($17.03) and ECCE
($16.25), due to the need for expensive equipment and consum-
ables for PHACO. The patients costs (direct and indirect ) were
highest for ECCEdue to the increased number of days required for
follow-up which incurs transportation and economic productivity
loss. As a result MSICS was the lowest cost, whereas PHACO and
ECCE had similar total costs (Muralikrishnan 2004). This study
only reports on the cost of cataract surgical procedures, not on
both costs and outcomes, which is what would be required for a
cost-effectiveness study. The evidence suggests that MSICS which
achieves similar visual outcome results to PHACO but is less ex-
pensive maybe the technique of choice. However further evalua-
tion of the cost-effectiveness of PHACO and MSICS is required
prior to a change in policy. Cost is an important issue as it has
proven to be one of the major barriers to the uptake of surgery
by patients in developing countries, especially in Nigeria, Nepal
(Yorston 2005) and Pakistan (Anjum 2006). Patients inmost com-
munities are willing to pay the equivalent of one month’s wages
for a cataract operation, therefore the cost of surgery should be
based on the paying capacity of the population being treated.
There are also few comparative studies assessing the effect of dif-
ferent cataract extraction techniques on functioning vision and
quality of life. Evaluation of cataract surgery outcomes should not
be based on postoperative visual acuity alone It is important to
show that the reduction in functional ability caused by cataract
can be reversed by surgery (Mamidipudi 2003). It would be useful
to evaluate quality of life, overall visual function and time taken to
resume daily activities/ work following each of the surgical tech-
niques. Solely considering visual outcomes does not give all the
answers to which surgical technique is preferable for the patient,
doctor or health care provider.
When assessing cataract surgical techniques outcome studies are
also useful sources. For example, Venkatesh 2005 was an outcome
study carried out at the same institute as MIOLS. In this case the
outcome study had less favourable visual outcomes than the ran-
domised controlled trial. This was thought to be the case because
MIOLS had strict exclusion criteria and the outcome study did
not exclude any patients with ocular co-morbidity. The outcome
study was designed to demonstrate what happens on a routine ba-
sis rather than compare the effectiveness of procedures. Outcome
studies are particularly useful for looking at adverse events such
as postoperative endophthalmitis (Montan 2002; West 2005) and
provide useful information for rare events but care must be taken
when interpreting results to assess for bias.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review provides evidence from nine randomised controlled
trials that phacoemulsification (PHACO) gives a better visual out-
come than extracapsular extraction with sutures. The majority of
these trials have been conducted in developed countries in a spe-
cialised hospital setting. Comparative clinical data between man-
ual small incision cataract surgery (MSICS), extracapsular extrac-
tion and phacoemulsification is only documented in a few studies
but has shown the former technique to give better visual results
than extracapsular cataract extraction (ECCE) and only slightly in-
ferior to phacoemulsification in a developing world setting. When
choosing the surgical procedure each patient should be examined
on a case by case basis as each surgical technique has its limitations.
The contraindications to MSICS include poor zonular integrity
as a result of pseudoexfoliation, decompensated cornea and hard
nuclear cataract (> grade IV).
Further work on cost / benefit of the introduction of sutureless
surgery (manual phacofragmentation or PHACO) in programmes
for the prevention of cataract blindness in the developing country
setting is needed.
This review also found evidence that ECCEwith a posterior cham-
ber lens implant provides better visual outcome than intracapsu-
lar extraction with aphakic glasses or anterior chamber intraocular
lens. This finding is based on the results of two trials. The data
in the review also suggests that intracapsular extraction with an
anterior chamber lens implant is an effective alternative to intra-
capsular extraction with aphakic glasses, with similar safety.
This review does not provide any evidence from controlled trials as
to the rates of corneal complications with anterior chamber lenses
more than seven or eight years after surgery. However, observa-
tional data from developed country settings do not indicate that
this is likely to be a problem. Posterior capsular opacification in
extracapsular extraction is common - the clinical implications in
the developing world have not yet been fully documented.
No comparative data from developing regions outside India are
available on the different surgical approaches and there are few
published studies to give a basis for cost benefit analysis comparing
the different surgical procedures.
Most young ophthalmologists in developing countries learn ex-
clusively extracapsular techniques as this has been adopted as the
primary surgery of choice. Technically MSICS is more difficult
than a standard manual ECCE. Additional skills of hydro-dissec-
tion and hydro-delineation are required for MSICS but these are
also useful for surgeons going on to learn PHACO. If these tech-
niques are to be included in a cataract management programme it
is important that ophthalmologists have received proper training
in the techniques.
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Implications for research
Considering the vast number of cataract surgical procedures per-
formedworldwide there are few randomised controlled trials com-
paring different surgical techniques. Further data from develop-
ing regions are needed to compare all aspects of intraocular lens
surgery with the four main surgical procedures - intracapsular ex-
traction with an anterior chamber lens, extracapsular surgery with
a posterior chamber lens with or without sutures, phacoemulsifi-
cation and manual small incision cataract surgery. To make com-
parisons of the data between studies possible we propose setting a
standard visual acuity recording system:
1. Uncorrected visual acuity (UCVA) and best corrected visual
acuity (BCVA) worse than 6/60, UCVA and BCVA worse than 6/
18 and UCVA and BCVA of better than 6/12.
2. Visual acuity recording postoperatively at six weeks and one
year. (Six weeks post operatively is the time at which refraction is
recommended as vision is thought to have stabilised).
3. Near vision to be recorded pre and postoperatively.
Further randomised controlled trials are required:
1. To compare ECCEwith PCIOL andMSICS with PCIOL with
longer term follow-up (preferably one, three and five years) to
assesswhether PCOoccursmore frequentlywith either technique.
2. A larger study with at least one year follow up is required to
compare PHACO andMSICS in terms of corneal endothelial cell
loss (George 2005 is the only RCT that looks at this and is a small
study with N = 53), and posterior capsular opacification. Other
outcomes of interest are intraoperative complications, visual acuity
and surgically induced astigmatism.
3. MSICS is performed by different techniques with variation in
incision shape and site (superior or temporal), type of capsulotomy
(continuous curvilinear, can opener or endocapsular) and use of
viscoelastic or AC maintainer. A study of the optimal surgical
technique comparing these variations is required.
4. To compare both the costs (providers and patients) and out-
comes of PHACO, ECCE and MSICS techniques.
5. To assess the effect of the surgical techniques on quality of life.
6. To assess the effect of the surgical techniques on near vision as
well as distance vision.
Techniques in cataract surgery are always changing but they are
not usually subjected to trials, rather trial and error. It is important
when considering trial design that a single surgeon performing
both procedures does not produce a surgeon effect. This is bias
introduced by a surgeon having more expertise in one interven-
tion as compared to the other. To reduce bias the patient should
be randomised to expert surgeons in each technique rather than
having the same surgeon performing both procedures (Devereaux
2005). It is difficult for large scale randomised controlled trials
(which take many years to execute, require long follow-up for rare
but important outcomes and are expensive) to keep pace with the
changing techniques and fashions but the evidence is needed be-
fore these changes are implemented.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Chee 1999
Methods Randomised controlled trial
Masking of outcome assessment: patient - yes; assessor - post op observer was masked to surgical procedure
(suture techniques different)
Participants Number randomised: 34 patients
Age: mean 63.06 years
Inclusion criteria: age-related cataract
Exclusion criteria: diabetics
Country: Singapore
Interventions Phaco versus ECCE
Maximum follow-up: 3 months (VA recorded at 2 months)
Outcomes Postoperative inflammation - laser flare meter/ slit lamp; VA
Notes 2 surgeons
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Dowler 2000
Methods Randomised controlled trial
Paired study: one type of surgery in each eye
Masking of outcome assessment: not reported. PHACO: suture less; ECCE: 5 sutures
Participants Number randomised: 46 patients
Age: Mean 66 (45 to 81) years
Inclusion criteria: diabetic patients; cataract sufficient to cause visual symptoms or impede fundus visual-
isation in both eyes
Exclusion criteria: clinically significant macular oedema at time of surgery; high risk proliferative retinopa-
thy at time of surgery; amblyopia; intercurrent ocular disease; history of prior ocular surgery
Country: UK
Interventions Phaco versus ECCE
Follow-up: 26 months (range 15 to 37)
Outcomes VA; anterior segment inflammation; capsulotomy; incidence of CSME; retinopathy progression
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Dowler 2000 (Continued)
Notes Sample size too small to detect a significant difference in the incidence of CSME or progression of
retinopathy between the two groups
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
George 2005
Methods Randomised controlled trial
Masking of outcome assessment: not reported. ECCE: sutured; PHACO&MSICS: not routinely sutured
unless wound leak
Participants Number randomised: 186 patients
Age: Mean 58.74 years
Inclusion criteria: patient undergoing planned cataract surgery; otherwise normal pre-op examination;
cataract < grade III
Exclusion criteria: other potential causes of decreased vision; complicated cataracts; non age-related
cataracts; phacodenesis; glaucoma or retinal pathology
Country: India
Interventions PHACO versus ECCE versus MSICS
Follow-up: 6 weeks
Outcomes SIA; EC - specular microscopy counts; VA
Notes 2 surgeons
PHACO - 5 mm incision rigid lens
MSICS - Blumenthal technique
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Gogate 2005
Methods Randomised controlled trial
Masking of outcome assessment: patient - yes; before, during and after surgery; assessor - yes.Post op
evaluation done by ophthalmologist who was not a participating surgeon and was masked as to the
treatment allocation code. Assessor may be able to determine the type of surgery involved as the IOL
in PHACO was foldable and in MSICS was PMMA. Location and size of suture (suture technique not
reported)
Participants Number randomised: 400 patients
Age: 40 to 90 years (mean 61.25 years)
Inclusion criteria: patients with cataract attending 20 July 2002 to 28 December 2003
Exclusion criteria: require combined surgical procedure; eye disorders that may compromise vision (eg.
amblyopia, glaucoma, diabetic retinopathy, macular degeneration); high myopes (axial length > 26.5mm)
; age <40 or >90; mobility thought to hinder follow-up; unable to give informed consent
Country: Pune, India
Interventions Phaco versus MSICS
Follow-up: 6 weeks
Outcomes VA; astigmatism; complications
Notes PHACO: Hydrophilic acrylic
ECCE: PMMA
Currently studying results of 1 year follow-up
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Katsimpris 2004
Methods Randomised controlled trial
Masking of outcome assessment: not reported. PHACO: 1 suture; ECCE: 4 to 5 sutures. Same IOL used
for both techniques
Participants Number randomised: 94 patients
Age: mean 76.3 years
Inclusion criteria: patients with cataract in association with pseudoexfoliation; small pupil; small to mod-
erate phacodenesis
Exclusion criteria: partial or complete subluxation; vitreous present in anterior chamber
Country: Greece
Interventions Phaco versus ECCE
Follow-up: Mean 14 ± 6.2 months
Outcomes Intraoperative complications; VA; PCO; IOL decentration; corneal oedema
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Katsimpris 2004 (Continued)
Notes 1 surgeon
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
LAHAN
Methods Randomised controlled trial
Masking of outcome assessment: patient and assessor - no. Obvious difference of one group wearing
aphakic glasses
Participants Number randomised: 2,000 patients
Age: 40 to 64 years (mean 55 years)
Inclusion criteria: bilateral cataract; VA 6/36 or worse in both eyes; live close by
Exclusion criteria: known pre-existing ocular disease; hypertension; diabetes
Country: Terai region, Nepal.
Interventions ICCE/AG versus ICCE/ACIOL
Follow-up: five years
Outcomes VA; blinding complication rate; causes of severe visual impairment
Notes ACIOL: single-piece four-point fixation CILCO Kelman Multiflex III lens (Alcon)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Landau 1999
Methods Randomised controlled trial
Masking of outcome assessment: patient and assessor - yes. UBM was performed by ophthalmogist who
was unaware of the surgical technique
Participants Number randomised: 42 patients
Age: mean 74.25 (68 to 82) years
Inclusion criteria: patients with cataract
Exclusion criteria: no other ocular disease
Country: Sweden
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Landau 1999 (Continued)
Interventions Phaco versus ECCE
Follow-up: mean 24 months (range 18 to 30)
Outcomes UBM - IOL haptic position; AC depth
Notes 1 surgeon
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Laurell 1998
Methods Randomised controlled trial
Masking of outcome assessment: patient and assessor - yes. Performed by a nurse and ophthalmologist
without knowledge of surgical technique
Participants Number randomised: 186 patients
Age: Mean 58.74 years
Inclusion criteria: patients enrolled for cataract surgery; age > 64
Exclusion criteria: pseudoexfoliation syndrome; small pupils (< 5mm post dilatation); glaucoma; uveitis;
dark brown irides; diabetes; treatment with eye drops or anti-inflammatory drugs
Country: Sweden
Interventions Phaco versus ECCE
Follow-up: 3 months
Outcomes Fluorophotometry; laser flare photometry; VA; pachymetry
Notes 1 surgeon
Blue iridies only
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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MEHOX
Methods Randomised controlled trial
(2 centre)
Masking of outcome assessment: patient and assessor - yes. Performed by an optometrist
Participants Number randomised: 500 patients
Age: 40+ (mean 72 years)
Inclusion criteria: consenting patient; age-related cataract; resident in the region; willing and able to attend
regular follow up
Exclusion criteria: hard, highly brunescent cataracts; eye disorders that may compromise vision (eg. am-
blyopia, glaucoma, diabetic retinopathy, macular degeneration); high myopes (axial length > 26.5 mm)
Country: UK
Interventions Phacoemulsification versus ECCE
Follow-up: 1 year
Outcomes VA; astigmatism; capsule rupture/vitreous loss; capsule opacity; endothelial cell loss
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
MIOLS
Methods Randomised controlled trial
Masking of outcome assessment: patient and assessor - no. Obvious difference of treatment group wearing
aphakic glasses
Participants Number randomised: 3,400 patients
Age: 40 to 70 years (mean 59 years)
Inclusion criteria: age 40 to 75; bilateral blindness caused by age-related cataract; VA 6/36 or worse in
better eye; within 150 km
Exclusion criteria: diabetics; hypertensive; patients who insisted on IOL; existence of ocular pathology;
non-ocular reasons - refused to participate; If preference to undergo either of the 2 procedures
Country: Madurai, south India
Interventions ICCE/AG versus ECCE/PCIOL
Follow-up: > 1 year
Outcomes VA; complications (OCTET grades); quality of life
Notes PCIOL: standard three-piece plano convex (Aurolab)
Risk of bias
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MIOLS (Continued)
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
OCTET
Methods Randomised controlled trial
Masking of outcome assessment: patient - no. Masked procedures reported for endothelial cell count,
reading fluorescein angiograms and refraction. Clinical assessment was not masked as obvious difference
of one treatment group wearing contact lens/ different IOL types
Participants Number randomised: 331 patients
Age: 55 to 90 years
Inclusion criteria: age 55 to 90; uncomplicated senile cataract; patient willing to wear a contact lens
Exclusion criteria: any patient with other ocular disease likely to affect visual outcome
Country: UK
Interventions ICCE/contact lens versus ICCE/iris supported versus ECCE/iridocapsular lens
Follow-up: 4 years
Outcomes VA; complications (OCTET grades); corneal endothelial cell loss (corneal endothelial cells were pho-
tographed using a non-contact specular microscope; cell density was assessed by grid counting)
Notes Iris supported lens: 4-loop iris supported Federov lens
Iridocapsular lens: 2-loop Binkhort iridocapsular lens
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
PUNE
Methods Randomised controlled trial
Masking of outcome assessment: patient - yes. Doctors (not participating surgeon) and optometrists were
assessors. Not told about the type of surgery done. Obviously unable to mask sutures, size and location
of incision
Participants Number randomised: 741 patients
Age: 40 to 90 years (mean 64.18 years)
Inclusion criteria: presented with cataract 7 April 2001 to 17 May 2001; age 40 to 90
Exclusion criteria: patient preference to one treatment; ocular co morbidity capable of compromising
vision; requirement for combined surgical procedure; axial length > 26 mm; refused to consent for study
Country: Pune, India
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PUNE (Continued)
Interventions ECCE versus MSICS
Follow-up: 6 weeks
Outcomes VA; complications (OCTET); cost
Notes 8 surgeons
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Ravalico 1997
Methods Randomised controlled trial
Masking of outcome assessment: not reported. PHACO: running cross suture, 3.2 mm incision; ECCE:
running cross suture, 10 mm incision
Participants Number randomised: 40 patients
Age: mean 63.5 (60 to 70) years
Inclusion criteria: not reported
Exclusion criteria: high refractive defects (> 4.0 dioptres); other ocular pathologies; diabetes mellitus;
intraoperative or postoperative complications
Country: Italy
Interventions Phaco versus ECCE
Follow-up: Mean 30 days
Outcomes Specular Microscopy - EC density, CV; pachymetry; anterior segment fluorophotometry - EC pump
function & permeability coefficient
VA
Notes 1 surgeon
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Rizal 2003
Methods Randomised controlled trial
Masking of outcome assessment: patient - yes; assessor - no
Participants Number randomised: 60 patients
Age: Mean 64.8 (45 to 94) years
Inclusion criteria: age > 40; BCVA 6/60 or better; first cataract surgery
Exclusion criteria: anxious patient who needs general anaesthetic; past history of eye injury; glaucoma;
maculopathy; poor pupil dilatation; vitreous haemorrhage; corneal opacity; mental or physical handicap;
major surgery; CVA with significant visual loss
Country: Malaysia
Interventions Phaco versus ECCE
Follow-up: mean 2 months
Outcomes Costs - hospital (recurrent / capital) and patient
Notes Short follow-up ECCE still need removal of sutures and 2 more appointments
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
SACMS
Methods Randomised controlled trial
(Multicentre)
Masking of outcome assessment: not reported.Obvious difference of one treatment groupwearing aphakic
glasses
Participants Number randomised: 1,237 patients
Age: 40 to 75 years (mean 61 years)
Inclusion criteria: age 40 to75; VA 6/60 or less, but a minimum of PL in 3 quadrants better eye; cataract
grade 2B and 3
Exclusion criteria: known or suspected glaucoma; IOP > 26 mm Hg; acute or chronic corneal disease;
shallow anterior chamber; anterior synechiae; congenital, complicated or traumatic cataract; nonlenticular
axial high myopia; one eye, aphakia, diabetic retinopathy; disease likely to cause death in 3 years
Countries: western Nepal; Chittagong, Bangladesh; Hyderabad, India
Interventions ICCE/AG versus ICCE/ACIOL
Follow-up: 2 years
Outcomes VA; causes of severe visual impairment; corneal endothelial cell loss (corneal endothelial cells were pho-
tographed using a non-contact specular microscope, images analysed using a semi-automated technique)
Notes ACIOL: single-piece four-point fixation CILCO Kelman Multiflex III lens (Alcon)
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SACMS (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Vogel 1993
Methods Randomised controlled trial
Masking of outcome assessment: not reported. Obviously unable to mask AC IOL and PC IOL from
assessors
Participants Number randomised: 360 patients
Age: 60 to 80 years (mean 73 years)
Inclusion criteria: age 60 to 80
Exclusion criterial: no other ocular disease compromising vision
Country: Germany
Interventions ICCE/ACIOL versus ECCE/PCIOL
Follow-up: 2 years
Outcomes VA; complications
Notes ACIOL: Choyce Mark IV
PCIOL: Ganz PMMA
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Waddell 2004
Methods Randomised controlled trial. Paired Study
Masking of outcome assessment: patient - yes. Not told the type of IOL implanted in each eye; assessor -
no. Type of IOL was obvious from examination of the eye
Participants Number randomised: 114 patients
Age: 50 to 80 years (mean 64 years)
Inclusion criteria: age = 50 years; bilateral cataract; VA 6/60 or worse in better eye
Exclusion criteria: VA worse than PL; significant keratopathy; glaucoma; ocular pathology; home too
inaccessible to visit
Country: Rural north and East Uganda
Interventions ECCE & PCIOL versus ICCE & ACIOL
Follow-up: 1 year
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Waddell 2004 (Continued)
Outcomes VA; complications; secondary procedures; refractive corrections
Notes 1 surgeon
ACIOL 4 feet mulitflex Aurolab, India
PCIOL Aurolab standard lens power
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
AG - aphakic glasses
ACIOL - anterior chamber intraocular lens
CSME - clinical significant macular oedema
ECCE - extracapsular extraction
ICCE - intracapsular extraction
IOL - intraocular lens
PCIOL - posterior chamber intraocular lens
VA - visual acuity
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alpar 1984 This was a small study in people with diabetes comparing intracapsular with extracapsular cataract extraction with
intraocular lens implantation. Several of the lenses they used are now no longer used. In addition, the trial was of
poor quality and did not present the outcomes of interest to our review, such as visual acuity
Bomer 1995 This was a study comparing the effect on intraocular pressure following phacoemulsification through scleral tunnel;
phacoemulsification and corneal incision and extracapsular extraction. We excluded this study since IOP was not
one of the outcome measures for this paper
Bourne 2003 This was a study looking at outcomes of cataract surgery in Bangladesh. This was not a randomised control trial
De Laage 1988 This study compared intracapsular extraction with an anterior
chamber lens in one eye compared with extracapsular extraction and posterior chamber lens in the other. The
allocation was not random, no concealment was mentioned and follow-up was only six months
Ford 2005 This study compared the effect of different surgical techniques on postoperative intra-ocular pressure. It was not
randomised and IOP is not an outcome measure for this paper
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(Continued)
Hsu 2005 This study compared phacoemulsificaction or extracapsular cataract extraction followed by pars plana vitrectomy
and PCIOL. Allocation concealment was not clear from the paper or whether randomisation was performed
Jurgens 1997 This study compared different types of viscoelastics. The surgical technique used was not randomised
Leen 1993 This study compared different incision sizes as opposed to different surgical techniques hence was excluded from
this review
Loo 2004 This study compared the cost-effectiveness and cost efficiency of phacoemulsifiaction and extracapsular extraction.
This was not a randomized control trial
Noske 1988 This study compared the effect of acetazolamide on IOP following phacoemulsification or extracapsular extraction.
IOP is not an outcome measure for this review
Quentin 1993 This study compared intracapsular cataract extraction with anterior chamber intraocular lens (Choyce Mark IX)
with extracapsular cataract extraction. Follow-up data included only six months after surgery
Ruellan 1994 This study compared phacoemulsification and extracapsular extraction. There was no information regarding allo-
cation concealment or randomisation in the paper hence there was a high risk of bias
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D A T A A N D A N A L Y S E S
Comparison 1. PHACOEMULSIFICATIONWITHPCIOLVERSUSEXTRACAPSULAREXTRACTIONWITH
PCIOL
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Clinical complications 2 571 Odds Ratio (M-H, Fixed, 95% CI) 0.25 [0.07, 0.91]
1.1 Macular oedema 2 571 Odds Ratio (M-H, Fixed, 95% CI) 0.25 [0.07, 0.91]
2 Complications during surgery 6 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
2.1 Iris Prolapse 6 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
2.2 PC Tear +/- Vitreous Loss 6 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 2. PHACOEMULSIFICATION WITH PCIOL VERSUS MANUAL SMALL INCISION EXTRAC-
TION WITH PCIOL
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Best corrected vision worse than
6/60, 4-12 weeks after surgery
2 485 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.14, 6.45]
2 Functional vision worse than
6/18, 4-12 weeks after surgery
2 485 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.19, 3.02]
3 Complications during surgery 2 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 PC Tear +/- Vit loss 2 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
Comparison 3. EXTRACAPSULAR EXTRACTION WITH PCIOL VERSUS MANUAL SMALL INCISION
EXTRACTION WITH PCIOL
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Best corrected vision worse than
6/60, 4-12 weeks after surgery
2 811 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.26, 2.49]
2 Functional vision worse than
6/18, 4-12 weeks after surgery
2 811 Risk Ratio (M-H, Fixed, 95% CI) 1.41 [0.94, 2.09]
3 Complications during surgery 2 Odds Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 PC Tear +/- Vit loss 2 Odds Ratio (M-H, Fixed, 95% CI) Not estimable
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Comparison 4. INTRACAPSULAR EXTRACTIONWITHACIOL VERSUS INTRACAPSULAR EXTRACTION
WITH GLASSES
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Best-corrected vision worse than
6/60, one year after surgery
2 2866 Risk Ratio (M-H, Fixed, 95% CI) 1.13 [0.74, 1.72]
2 Functional vision worse than
6/18, one year after surgery
2 2867 Risk Ratio (M-H, Fixed, 95% CI) 1.25 [1.16, 1.35]
3 Clinical complications 2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
3.1 Retinal detachment 2 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.2 Macular oedema 2 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
3.3 Corneal decompensation 2 Risk Ratio (M-H, Fixed, 95% CI) Not estimable
Analysis 1.1. Comparison 1 PHACOEMULSIFICATIONWITH PCIOL VERSUS EXTRACAPSULAR
EXTRACTIONWITH PCIOL, Outcome 1 Clinical complications.
Review: Surgical interventions for age-related cataract
Comparison: 1 PHACOEMULSIFICATION WITH PCIOL VERSUS EXTRACAPSULAR EXTRACTION WITH PCIOL
Outcome: 1 Clinical complications
Study or subgroup PHACO ECCE Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Macular oedema
Katsimpris 2004 1/47 8/47 71.9 % 0.11 [ 0.01, 0.88 ]
MEHOX 2/245 3/232 28.1 % 0.63 [ 0.10, 3.79 ]
Total (95% CI) 292 279 100.0 % 0.25 [ 0.07, 0.91 ]
Total events: 3 (PHACO), 11 (ECCE)
Heterogeneity: Chi2 = 1.63, df = 1 (P = 0.20); I2 =39%
Test for overall effect: Z = 2.10 (P = 0.036)
0.05 0.2 1 5 20
Favours PHACO Favours ECCE
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Analysis 1.2. Comparison 1 PHACOEMULSIFICATIONWITH PCIOL VERSUS EXTRACAPSULAR
EXTRACTIONWITH PCIOL, Outcome 2 Complications during surgery.
Review: Surgical interventions for age-related cataract
Comparison: 1 PHACOEMULSIFICATION WITH PCIOL VERSUS EXTRACAPSULAR EXTRACTION WITH PCIOL
Outcome: 2 Complications during surgery
Study or subgroup PHACO ECCE Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Iris Prolapse
Chee 1999 0/18 0/16 Not estimable
George 2005 0/60 0/52 Not estimable
Katsimpris 2004 0/47 0/47 Not estimable
Landau 1999 0/18 0/17 Not estimable
Laurell 1998 0/21 0/21 Not estimable
MEHOX 0/246 17/236 0.03 [ 0.00, 0.45 ]
2 PC Tear +/- Vitreous Loss
Chee 1999 0/18 0/16 Not estimable
George 2005 0/60 0/52 Not estimable
Katsimpris 2004 2/47 8/47 0.25 [ 0.06, 1.12 ]
Landau 1999 0/18 0/17 Not estimable
Laurell 1998 0/21 0/21 Not estimable
MEHOX 8/246 9/236 0.85 [ 0.33, 2.17 ]
0.1 0.2 0.5 1 2 5 10
Favours Phaco Favours ECCE
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Analysis 2.1. Comparison 2 PHACOEMULSIFICATIONWITH PCIOL VERSUS MANUAL SMALL
INCISION EXTRACTIONWITH PCIOL, Outcome 1 Best corrected vision worse than 6/60, 4-12 weeks after
surgery.
Review: Surgical interventions for age-related cataract
Comparison: 2 PHACOEMULSIFICATION WITH PCIOL VERSUS MANUAL SMALL INCISION EXTRACTION WITH PCIOL
Outcome: 1 Best corrected vision worse than 6/60, 4-12 weeks after surgery
Study or subgroup PHACO MSICS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
George 2005 0/60 1/53 76.2 % 0.30 [ 0.01, 7.09 ]
Gogate 2005 1/185 0/187 23.8 % 3.03 [ 0.12, 73.96 ]
Total (95% CI) 245 240 100.0 % 0.95 [ 0.14, 6.45 ]
Total events: 1 (PHACO), 1 (MSICS)
Heterogeneity: Chi2 = 1.03, df = 1 (P = 0.31); I2 =3%
Test for overall effect: Z = 0.06 (P = 0.96)
0.1 0.2 0.5 1 2 5 10
Favours PHACO Favours MSICS
Analysis 2.2. Comparison 2 PHACOEMULSIFICATIONWITH PCIOL VERSUS MANUAL SMALL
INCISION EXTRACTIONWITH PCIOL, Outcome 2 Functional vision worse than 6/18, 4-12 weeks after
surgery.
Review: Surgical interventions for age-related cataract
Comparison: 2 PHACOEMULSIFICATION WITH PCIOL VERSUS MANUAL SMALL INCISION EXTRACTION WITH PCIOL
Outcome: 2 Functional vision worse than 6/18, 4-12 weeks after surgery
Study or subgroup PHACO MSICS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
George 2005 0/60 1/53 34.8 % 0.30 [ 0.01, 7.09 ]
Gogate 2005 3/185 3/187 65.2 % 1.01 [ 0.21, 4.94 ]
Total (95% CI) 245 240 100.0 % 0.76 [ 0.19, 3.02 ]
Total events: 3 (PHACO), 4 (MSICS)
Heterogeneity: Chi2 = 0.46, df = 1 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 0.39 (P = 0.70)
0.1 0.2 0.5 1 2 5 10
Favours PHACO Favours MSICS
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Analysis 2.3. Comparison 2 PHACOEMULSIFICATIONWITH PCIOL VERSUS MANUAL SMALL
INCISION EXTRACTIONWITH PCIOL, Outcome 3 Complications during surgery.
Review: Surgical interventions for age-related cataract
Comparison: 2 PHACOEMULSIFICATION WITH PCIOL VERSUS MANUAL SMALL INCISION EXTRACTION WITH PCIOL
Outcome: 3 Complications during surgery
Study or subgroup PHACO MSICS Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PC Tear +/- Vit loss
George 2005 0/60 0/53 Not estimable
Gogate 2005 7/199 12/201 0.57 [ 0.22, 1.49 ]
0.1 0.2 0.5 1 2 5 10
Favours PHACO Favours MSICS
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Analysis 3.1. Comparison 3 EXTRACAPSULAR EXTRACTIONWITH PCIOL VERSUS MANUAL SMALL
INCISION EXTRACTIONWITH PCIOL, Outcome 1 Best corrected vision worse than 6/60, 4-12 weeks after
surgery.
Review: Surgical interventions for age-related cataract
Comparison: 3 EXTRACAPSULAR EXTRACTION WITH PCIOL VERSUS MANUAL SMALL INCISION EXTRACTION WITH PCIOL
Outcome: 1 Best corrected vision worse than 6/60, 4-12 weeks after surgery
Study or subgroup ECCE MSICS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
George 2005 1/53 0/52 7.6 % 2.94 [ 0.12, 70.67 ]
PUNE 4/362 6/344 92.4 % 0.63 [ 0.18, 2.23 ]
Total (95% CI) 415 396 100.0 % 0.81 [ 0.26, 2.49 ]
Total events: 5 (ECCE), 6 (MSICS)
Heterogeneity: Chi2 = 0.78, df = 1 (P = 0.38); I2 =0.0%
Test for overall effect: Z = 0.37 (P = 0.71)
0.1 0.2 0.5 1 2 5 10
Favours ECCE Favours MSICS
Analysis 3.2. Comparison 3 EXTRACAPSULAR EXTRACTIONWITH PCIOL VERSUS MANUAL SMALL
INCISION EXTRACTIONWITH PCIOL, Outcome 2 Functional vision worse than 6/18, 4-12 weeks after
surgery.
Review: Surgical interventions for age-related cataract
Comparison: 3 EXTRACAPSULAR EXTRACTION WITH PCIOL VERSUS MANUAL SMALL INCISION EXTRACTION WITH PCIOL
Outcome: 2 Functional vision worse than 6/18, 4-12 weeks after surgery
Study or subgroup ECCE MSICS Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
George 2005 5/52 1/53 2.7 % 5.10 [ 0.62, 42.15 ]
PUNE 48/362 35/344 97.3 % 1.30 [ 0.86, 1.96 ]
Total (95% CI) 414 397 100.0 % 1.41 [ 0.94, 2.09 ]
Total events: 53 (ECCE), 36 (MSICS)
Heterogeneity: Chi2 = 1.56, df = 1 (P = 0.21); I2 =36%
Test for overall effect: Z = 1.67 (P = 0.095)
0.1 0.2 0.5 1 2 5 10
Favours ECCE Favours MSICS
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Analysis 3.3. Comparison 3 EXTRACAPSULAR EXTRACTIONWITH PCIOL VERSUS MANUAL SMALL
INCISION EXTRACTIONWITH PCIOL, Outcome 3 Complications during surgery.
Review: Surgical interventions for age-related cataract
Comparison: 3 EXTRACAPSULAR EXTRACTION WITH PCIOL VERSUS MANUAL SMALL INCISION EXTRACTION WITH PCIOL
Outcome: 3 Complications during surgery
Study or subgroup ECCE MSICS Odds Ratio Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PC Tear +/- Vit loss
George 2005 0/52 0/53 Not estimable
PUNE 10/383 18/358 0.51 [ 0.23, 1.11 ]
0.1 0.2 0.5 1 2 5 10
Favours ECCE Favours MSICS
39Surgical interventions for age-related cataract (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.1. Comparison 4 INTRACAPSULAR EXTRACTIONWITH ACIOL VERSUS INTRACAPSULAR
EXTRACTIONWITH GLASSES, Outcome 1 Best-corrected vision worse than 6/60, one year after surgery.
Review: Surgical interventions for age-related cataract
Comparison: 4 INTRACAPSULAR EXTRACTION WITH ACIOL VERSUS INTRACAPSULAR EXTRACTION WITH GLASSES
Outcome: 1 Best-corrected vision worse than 6/60, one year after surgery
Study or subgroup ICCE-ACIOL ICCE-AG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
LAHAN 24/917 20/909 51.4 % 1.19 [ 0.66, 2.14 ]
SACMS 20/519 19/521 48.6 % 1.06 [ 0.57, 1.96 ]
Total (95% CI) 1436 1430 100.0 % 1.13 [ 0.74, 1.72 ]
Total events: 44 (ICCE-ACIOL), 39 (ICCE-AG)
Heterogeneity: Chi2 = 0.07, df = 1 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59)
0.1 0.2 0.5 1 2 5 10
Favours ICCE-ACIOL Favours ICCE-AG
Analysis 4.2. Comparison 4 INTRACAPSULAR EXTRACTIONWITH ACIOL VERSUS INTRACAPSULAR
EXTRACTIONWITH GLASSES, Outcome 2 Functional vision worse than 6/18, one year after surgery.
Review: Surgical interventions for age-related cataract
Comparison: 4 INTRACAPSULAR EXTRACTION WITH ACIOL VERSUS INTRACAPSULAR EXTRACTION WITH GLASSES
Outcome: 2 Functional vision worse than 6/18, one year after surgery
Study or subgroup ICCE-IOL ICCE-AG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
LAHAN 502/918 369/909 60.6 % 1.35 [ 1.22, 1.49 ]
SACMS 264/519 242/521 39.4 % 1.10 [ 0.97, 1.24 ]
Total (95% CI) 1437 1430 100.0 % 1.25 [ 1.16, 1.35 ]
Total events: 766 (ICCE-IOL), 611 (ICCE-AG)
Heterogeneity: Chi2 = 6.51, df = 1 (P = 0.01); I2 =85%
Test for overall effect: Z = 5.62 (P < 0.00001)
0.1 0.2 0.5 1 2 5 10
Favours ICCE-ACIOL Favours ICCE-AG
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Analysis 4.3. Comparison 4 INTRACAPSULAR EXTRACTIONWITH ACIOL VERSUS INTRACAPSULAR
EXTRACTIONWITH GLASSES, Outcome 3 Clinical complications.
Review: Surgical interventions for age-related cataract
Comparison: 4 INTRACAPSULAR EXTRACTION WITH ACIOL VERSUS INTRACAPSULAR EXTRACTION WITH GLASSES
Outcome: 3 Clinical complications
Study or subgroup ICCE-ACIOL ICCE-AG Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Retinal detachment
LAHAN 0/918 4/909 0.11 [ 0.01, 2.04 ]
SACMS 2/519 4/521 0.50 [ 0.09, 2.73 ]
2 Macular oedema
LAHAN 2/918 0/909 4.95 [ 0.24, 102.98 ]
SACMS 3/519 2/521 1.51 [ 0.25, 8.97 ]
3 Corneal decompensation
LAHAN 0/918 1/909 0.33 [ 0.01, 8.09 ]
SACMS 1/519 1/521 1.00 [ 0.06, 16.01 ]
0.1 0.2 0.5 1 2 5 10
Favours ICCE-ACIOL Favours ICCE-AG
A D D I T I O N A L T A B L E S
Table 1. Heterogeneity of visual outcome data for PHACO with IOL versus ECCE with PCIOL
Study Post op follow up BCVA/BSCVA data UCVA data
MEHOX 3 weeks, 6 weeks, 3 months, 6
months, 12 months
BSCVA of 6/9 or better; BSCVA of
6/12 or better (12 months only)
UCVA of 6/9 or better
Dowler 2000 only 1 year data presented (although
VA also recorded at 6 months)
Median BCVA UCVA not recorded
Katsimpris 2004 14 months Mean BCVA UCVA not recorded
Chee 1999 VA was only reported at 2 months
(although maximum follow up time
was 3 months)
BCVA of 6/12 or better UCVA of 6/12 or better
George 2005 6 weeks BCVA of 6/12 or better UCVA not recorded
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Table 1. Heterogeneity of visual outcome data for PHACO with IOL versus ECCE with PCIOL (Continued)
Laurell 1998 1 day, 3 days, 3 months BCVA of 6/9 or better (1 day only);
BCVA of 6/6 (3 days and 3 months)
UCVA of 20/100 or less (1 day and
3 days only)
Ravalico 1997 7 days, 30 days Mean BCVA UCVA is not presented (although
was performed)
Table 2. Postoperative BCVA results for PHACO with PCIOL versus ECCE with PCIOL studies
Study Early visual outcome Late visual outcome
MEHOX BCVA 6/9 or better at 6 weeks (12 weeks) - PHACO:
90% (93%); ECCE: 78% (80%)
BCVA 6/9 or better at 12 months - PHACO: 91%;
ECCE: 86%
Dowler 2000 Not recorded BCVA 6/12 or better at 12 months - PHACO: 96%;
ECCE: 83%
Katsimpris 2004 Not recorded Mean BCVA decimal at 14 months - PHACO: 0.5;
ECCE: 0.3
Chee 1999 BCVA 6/12 or better at 8 weeks - PHACO: 94%;
ECCE: 94%
Not recorded
George 2005 BCVA 6/12 or better at 6 weeks - PHACO: 100%;
ECCE: 90%
Not recorded
Laurell 1998 BCVA 6/6 or better at 12 weeks - PHACO: 76%;
ECCE: 45%
Not recorded
Ravalico 1997 Mean BCVA at 4 weeks - PHACO: 0.95 ± 0.11; ECCE:
0.92 ± 0.10
Not recorded
42Surgical interventions for age-related cataract (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A P P E N D I C E S
Appendix 1. CENTRAL search strategy for Issue 3, 2006 and NRR search strategy for Issue 3, 2005
#1 CATARACT EXTRACTION
#2 LENS CRYSTALLINE/su
#3 CAPSULORHEXIS
#4 PHACOEMULSIFICATION
#5 LENS IMPLANTATION INTRAOCULAR
#6 ((lens* near opac*) and (extract* or remov* or operat* or aspirat* or surg*))
#7 (cataract* and (extract* or remov* or operat* or aspirat* or surg*))
#8 ((intra-capsular or extra-capsular or phako* or phaco* or sutureless) and cataract*)
#9 ((intra-ocular next lens*) and implant*)
#10 (enzymatic near zonulolysis)
#11 (crystalline near surg*)
#12 (capsulorhexis or capsulorrhexis)
#13 (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12)
#14 (age* near relat*)
#15 (#13 and #14)
Appendix 2. MEDLINE search strategy used up to July 2006
#1 explode “Cataract-Extraction” / all SUBHEADINGS in MIME,MJME
#2 explode “Lens-Crystalline” / surgery in MIME,MJME
#3 explode “Capsulorhexis-” / all SUBHEADINGS in MIME,MJME
#4 explode “Phacoemulsification-” / all SUBHEADINGS in MIME,MJME
#5 explode “Lens-Implantation-Intraocular” / all SUBHEADINGS in MIME,MJME
#6 ( ((lens* near opac*) near (extract* or remov* or operat* or aspirat* or surg*)).) in TI )or( ((lens* near opac*) near (extract* or remov*
or operat* or aspirat* or surg*)).) in AB )
#7 ( (cataract* near (extract* or remov* or operat* or aspirat* or surg*)).) in TI )or( (extract* or remov* or operat* or aspirat* or
surg*)).))) in AB)
#8 ( (intra?capsular or extra?capsular or pha?o* or sutureless) near ((cataract*) in TI )or( (intra?capsular or extra?capsular or pha?o* or
sutureless) near ((cataract*) in AB )
#9 ( (intra?ocular next lens*) near ((implant*) in TI) )or( (intra?ocular next lens*) near ((implant*) in AB) )
#10 ( (enzymatic zonulolysis) in TI )or( (enzymatic zonulolysis) in AB )
#11 ( (crystalline near surg*) in TI )or( (crystalline near surg*) in AB )
#12 ( (capsulor?hexis) in TI )or( (capsulor?hexis) in AB )
#13 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13
#14 age* near relat*
#15 #13 AND #14
To identify randomised controlled trials, we combined this search with the Cochrane Highly Sensitive Search Strategy phases one and
two as contained in the Cochrane Handbook for Systematic Reviews of interventions (Higgins 2005a).
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Appendix 3. EMBASE search strategy used up to July 2006
#1 exp Cataract Extraction/
#2 exp lens/
#3 su.fs.
#4 2 and 3
#5 exp CAPSULORHEXIS/
#6 exp PHACOEMULSIFICATION/
#7 exp Lens Implantation/
#8 1 or 4 or 5 or 6 or 7
#9 (lens$ adj3 opac$ adj5 (extract$ or remov$ or operat$ or aspirat$ or surg$)).ab,ti.
#10 (cataract$ adj3 (extract$ or remov$ or operat$ or aspirat$ or surg$)).ab,ti.
#11 ((intracapsular or intra-capsular or extracapsular or extra-capsular or phaco$ or phako$ or sutureless) adj5 cataract$).ab,ti.
#12 ((intraocular or intra-ocular) adj3 lens$ adj3 implant$).ab,ti.
#13 enzymatic zonulolysis.ab,ti.
#14 exp zonulolysis/
#15 (crystalline adj3 surg$).ab,ti.
#16 (capsulorhexis or capsulorrhexis).ab,ti.
#17 catarectomy.ab,ti.
#18 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17
#19 8 or 18
#20 (2001$ or 2002$ or 2003$ or 2004$ or 2005$).em.
#21 19 and 20
#22 elderly care.sh.
#23 exp senescence/
#24 Aged/
#25 (old$ adj3 age$).ab,ti.
#26 (age$ adj3 related).ab,ti.
#27 pensioner.sh.
#28 (aged or elderly or pensioner$ or (old adj3 age$)).ab,ti.
#29 21 and 28
#30 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29
#31 21 and 30
To identify randomised controlled trials, this search was combined with the following search:
#1 Randomized Controlled Trial/
#2 exp Randomization/
#3 Double Blind Procedure/
#4 Single Blind Procedure/
#5 random$.ab,ti.
#6 #1 or #2 or #3 or #4 or #5
#7 (animal or animal experiment).sh.
#8 human.sh.
#9 #7 and #8
#10 #7 not #9
#11 #6 not #10
#12 Clinical Trial/
#13 (clin$ adj3 trial$).ab,ti.
#14 ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$)).ab,ti.
#15 exp PLACEBO/
#16 placebo$.ab,ti.
#17 random$.ab,ti.
#18 experimental design/
#19 Crossover Procedure/
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#20 exp Control Group/
#21 exp LATIN SQUARE DESIGN/
#22 #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21
#23 #22 not #10
#24 #23 not #11
#25 exp Comparative Study/
#26 exp Evaluation/
#27 exp Prospective Study/
#28 (control$ or prospectiv$ or volunteer$).ab,ti.
#29 #25 or #26 or #27 or #28
#30 #29 not #10
#31 #30 not (#11 or #23)
#32 #11 or #24 or #31
WH A T ’ S N E W
Last assessed as up-to-date: 22 August 2006.
Date Event Description
3 November 2008 Amended Converted to new review format.
H I S T O R Y
Protocol first published: Issue 4, 1998
Review first published: Issue 2, 2002
Date Event Description
23 August 2006 New citation required and conclusions have changed Substantive amendment
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D E C L A R A T I O N S O F I N T E R E S T
Four of the co-authors (JE, AF, TR,TS) have been involved in the funding, design, execution and analysis of three of the trials included
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